Edgar Haber - Publications

Affiliations: 
1964-1988 Harvard Medical School, Boston, MA, United States 
Area:
Immunochemistry
Website:
https://www.geni.com/people/EDGAR-HABER/6000000031898901839

437 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Burke E, Haber E, Pike CW, Sonti R. Outcomes of renal replacement therapy in the critically ill with COVID-19. Medicina Intensiva. 45: 325-331. PMID 34629584 DOI: 10.1016/j.medin.2021.02.004  1
2021 Burke E, Haber E, Pike CW, Sonti R. Outcomes of renal replacement therapy in the critically ill with COVID-19. Medicina Intensiva. 45: 325-331. PMID 34294231 DOI: 10.1016/j.medine.2021.02.006  1
2021 Burke E, Haber E, Pike CW, Sonti R. Outcomes of renal replacement therapy in the critically ill with COVID-19. Medicina Intensiva. PMID 33726959 DOI: 10.1016/j.medin.2021.02.004  0.01
2021 Sparapani S, Millet-Boureima C, Oliver J, Mu K, Hadavi P, Kalostian T, Ali N, Avelar CM, Bardies M, Barrow B, Benedikt M, Biancardi G, Bindra R, Bui L, Chihab Z, ... ... Haber E, et al. The Biology of Vasopressin. Biomedicines. 9. PMID 33477721 DOI: 10.3390/biomedicines9010089  0.01
2020 Eppinga MB, Baudena M, Haber EA, Rietkerk M, Wassen MJ, Santos MJ. Spatially explicit removal strategies increase the efficiency of invasive plant species control. Ecological Applications : a Publication of the Ecological Society of America. e2257. PMID 33159346 DOI: 10.1002/eap.2257  0.01
2019 ElKabbash M, Miele E, Fumani AK, Wolf MS, Bozzola A, Haber E, Shahbazyan TV, Berezovsky J, De Angelis F, Strangi G. Cooperative Energy Transfer Controls the Spontaneous Emission Rate Beyond Field Enhancement Limits. Physical Review Letters. 122: 203901. PMID 31172774 DOI: 10.1103/Physrevlett.122.203901  0.01
2018 Elkin R, Nadeem S, Haber E, Steklova K, Lee H, Benveniste H, Tannenbaum A. GlymphVIS: Visualizing Glymphatic Transport Pathways Using Regularized Optimal Transport. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 11070: 844-852. PMID 30906935 DOI: 10.1007/978-3-030-00928-1_95  1
2017 Cowan RA, Haber EN, Faucz FR, Stratakis CA, Gomez-Lobo V. Mucinous Cystadenoma in Children and Adolescents. Journal of Pediatric and Adolescent Gynecology. PMID 28216128 DOI: 10.1016/j.jpag.2017.02.001  0.01
2016 Van Lieshout RJ, Yang L, Haber E, Ferro MA. Evaluating the effectiveness of a brief group cognitive behavioural therapy intervention for perinatal depression. Archives of Women's Mental Health. PMID 27613531 DOI: 10.1007/s00737-016-0666-9  0.01
2015 Haber E, Ravekes W, Koestenberger M. Decreased tricuspid annular peak systolic velocity (S') and N-terminal B-type natriuretic pro-peptide values in children after tetralogy of Fallot repair. Kardiologia Polska. 73: 381. PMID 25997492 DOI: 10.5603/KP.2015.0081  1
2015 Green SM, Haber E, Frey BN, McCabe RE. Cognitive-behavioral group treatment for perinatal anxiety: a pilot study. Archives of Women's Mental Health. 18: 631-8. PMID 25652951 DOI: 10.1007/S00737-015-0498-Z  1
2015 McMillan MS, Schwarzbach C, Haber E, Oldenburg DW. 3D parametric hybrid inversion of time-domain airborne electromagnetic data Geophysics. 80: K25-K36. DOI: 10.1190/Geo2015-0141.1  1
2015 Hoversten GM, Commer M, Haber E, Schwarzbach C. Hydro-frac monitoring using ground time-domain electromagnetics Geophysical Prospecting. 63: 1508-1526. DOI: 10.1111/1365-2478.12300  1
2015 Maglio PP, Kandogan E, Haber E, Bailey J. How tangential problems limit value creation in IT-based service systems Proceedings of the Annual Hawaii International Conference On System Sciences. 2015: 1453-1461. DOI: 10.1109/HICSS.2015.177  1
2015 Haber E, van den Doel K, Horesh L. Optimal design of simultaneous source encoding Inverse Problems in Science and Engineering. 23: 780-797. DOI: 10.1080/17415977.2014.934821  1
2015 McMillan MS, Oldenburg DW, Haber E, Schwarzbach C, Holtham E. 3D multiple body parametric inversion of timedomain airborne EM data 1st European Airborne Electromagnetics Conference - Held At Near Surface Geoscience 2015. 51-55.  1
2014 Kandogan E, Balakrishnan A, Haber EM, Pierce JS. From data to insight: work practices of analysts in the enterprise. Ieee Computer Graphics and Applications. 34: 42-50. PMID 25248199 DOI: 10.1109/Mcg.2014.62  1
2014 Haber E, Ravekes W, Koestenberger M. Decreased tricuspid annular peak systolic velocity (S′) and N-terminal B-type natriuretic pro-peptide values in children after tetralogy of Fallot repair Kardiologia Polska. 73: 381. DOI: 10.5603/KP.2015.0081  1
2014 Marchant D, Haber E, Oldenburg DW. Three-dimensional modeling of IP effects in time-domain electromagnetic data Geophysics. 79: E303-E314. DOI: 10.1190/Geo2014-0060.1  1
2014 Badenes H, Bengualid MN, Chen J, Gou L, Haber E, Mahmud J, Nichols JW, Pal A, Schoudt J, Smith BA, Xuan Y, Yang H, Zhou MX. System U: Automatically deriving personality traits from social media for people recommendation Recsys 2014 - Proceedings of the 8th Acm Conference On Recommender Systems. 373-374. DOI: 10.1145/2645710.2645719  1
2014 Fohring J, Haber E, Ruthotto L. Geophysical imaging of fluid flow in porous media Siam Journal On Scientific Computing. 36: S218-S236. DOI: 10.1137/130925232  1
2014 Yang D, Oldenburg DW, Haber E. 3-D inversion of airborne electromagnetic data parallelized and accelerated by local mesh and adaptive soundings Geophysical Journal International. 196: 1492-1507. DOI: 10.1093/Gji/Ggt465  1
2014 Haber E, Schwarzbach C. Parallel inversion of large-scale airborne time-domain electromagnetic data with multiple OcTree meshes Inverse Problems. 30. DOI: 10.1088/0266-5611/30/5/055011  1
2014 Mahmud J, Cypher A, Haber E, Lau T. Design and industrial evaluation of a tool supporting semi-automated website testing Software Testing Verification and Reliability. 24: 61-82. DOI: 10.1002/Stvr.1484  1
2014 Haber E. Advanced modeling and inversion tools for controlled source em 76th Eage Conference and Exhibition 2014, Workshops. 231-233.  1
2014 Hoversten GM, Commer M, Haber E, Schwarzbach C. Hydro-frac monitoring using ground time-domain em 76th Eage Conference and Exhibition 2014, Workshops. 262-264.  1
2013 Green SM, Haber E, McCabe RE, Soares CN. Cognitive-behavioral group treatment for menopausal symptoms: a pilot study. Archives of Women's Mental Health. 16: 325-32. PMID 23604545 DOI: 10.1007/S00737-013-0339-X  1
2013 Frey BN, Haber E, Mendes GC, Steiner M, Soares CN. Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder. Archives of Women's Mental Health. 16: 83-5. PMID 23143411 DOI: 10.1007/S00737-012-0314-Y  1
2013 Oldenburg DW, Haber E, Shekhtman R. Three dimensional inversion of multisource time domain electromagnetic data Geophysics. 78: E47-E57. DOI: 10.1190/Geo2012-0131.1  1
2013 Gou L, Mahmud J, Haber EM, Zhou MX. PersonalityViz: A visualization tool to analyze people's personality with social media International Conference On Intelligent User Interfaces, Proceedings Iui. 45-46. DOI: 10.1145/2451176.2451191  1
2013 Zhou MX, Wang F, Zimmerman T, Yang H, Haber E, Gou L. Computational discovery of personal traits from social multimedia Electronic Proceedings of the 2013 Ieee International Conference On Multimedia and Expo Workshops, Icmew 2013. DOI: 10.1109/ICMEW.2013.6618398  1
2013 Schwarzbach C, Haber E. Finite element based inversion for time-harmonic electromagnetic problems Geophysical Journal International. 193: 615-634. DOI: 10.1093/Gji/Ggt006  1
2013 Marchant D, Haber E, Oldenburg DW. Inductive source induced polarization Geophysical Journal International. 192: 602-612. DOI: 10.1093/Gji/Ggs040  1
2013 Kandogan E, Maglio P, Haber E, Bailey J. Taming Information Technology: Lessons from Studies of System Administrators Taming Information Technology: Lessons From Studies of System Administrators. 1-310. DOI: 10.1093/acprof:oso/9780195374124.001.0001  1
2013 Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H. Corrigendum to "Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice" [Exp. Neurol. 224/2 (2010) 472-485] Experimental Neurology. 247: 8. DOI: 10.1016/j.expneurol.2013.03.013  1
2013 Knight S, Hauxwell J, Haber EA. Distribution and Abundance of Aquatic Plants - Human Impacts Reference Module in Earth Systems and Environmental Sciences. DOI: 10.1016/B978-0-12-409548-9.09102-8  1
2013 Haber E, Holtzman Gazit M. Model Fusion and Joint Inversion Surveys in Geophysics. 34: 675-695. DOI: 10.1007/S10712-013-9232-4  1
2013 Hu M, Yang H, Zhou MX, Gou L, Li Y, Haber E. OpinionBlocks: A crowd-powered, self-improving interactive visual analytic system for understanding opinion text Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 8118: 116-134. DOI: 10.1007/978-3-642-40480-1_8  1
2012 Huang H, Haber E, Horesh L. Optimal estimation of l 1-regularization prior from a regularized empirical bayesian risk standpoint Inverse Problems and Imaging. 6: 447-464. DOI: 10.3934/Ipi.2012.6.447  1
2012 Hawkey K, Haber EM. GROUP workshop proposal collaboration in managing computer systems Group'12 - Proceedings of the Acm 2012 International Conference On Support Group Work. 321-322. DOI: 10.1145/2389176.2389238  1
2012 Haber E, Chung M, Herrmann F. An effective method for parameter estimation with PDE constraints with multiple right-hand sides Siam Journal On Optimization. 22: 739-757. DOI: 10.1137/11081126X  1
2012 Chung M, Haber E. Experimental design for biological systems Siam Journal On Control and Optimization. 50: 471-489. DOI: 10.1137/100791063  1
2012 Royer AA, Bostock MG, Haber E. Blind deconvolution of seismograms regularized via minimum support Inverse Problems. 28. DOI: 10.1088/0266-5611/28/12/125010  1
2012 Haber E, Magnant Z, Lucero C, Tenorio L. Numerical methods for A-optimal designs with a sparsity constraint for ill-posed inverse problems Computational Optimization and Applications. 52: 293-314. DOI: 10.1007/S10589-011-9404-4  1
2011 Faber TL, Santana CA, Piccinelli M, Nye JA, Votaw JR, Garcia EV, Haber E. Automatic Alignment of Myocardial Perfusion Images With Contrast-Enhanced Cardiac Computed Tomography. Ieee Transactions On Nuclear Science. 58: 2296-2302. PMID 24825924 DOI: 10.1109/Tns.2011.2163526  1
2011 Lahiani-Cohen I, Lourbopoulos A, Haber E, Rozenstein-Tsalkovich L, Abramsky O, Grigoriadis N, Rosenmann H. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model. Journal of Neuropathology and Experimental Neurology. 70: 610-21. PMID 21666497 DOI: 10.1097/NEN.0b013e318221bfab  1
2011 Schwarzbach C, Haber E. Finite element based inversion for electromagnetic problems using stochastic optimization Seg Technical Program Expanded Abstracts. 30: 567-572. DOI: 10.1190/1.3628145  1
2011 Kim S, Robson C, Zimmerman T, Pierce J, Haber EM. Creek watch: Pairing usefulness and usability for successful citizen science Conference On Human Factors in Computing Systems - Proceedings. 2125-2134. DOI: 10.1145/1978942.1979251  1
2011 Haber EM, Kandogan E, Maglio PP. Collaboration in system administration Communications of the Acm. 54: 46-53. DOI: 10.1145/1866739.1866755  1
2011 Horesh L, Haber E. A second order discretization of Maxwell's equations in the quasi-static regime on octree grids Siam Journal On Scientific Computing. 33: 2805-2822. DOI: 10.1137/100798508  1
2011 Haber E, MacLachlan S. A fast method for the solution of the Helmholtz equation Journal of Computational Physics. 230: 4403-4418. DOI: 10.1016/J.Jcp.2011.01.015  1
2011 Kandogan E, Maglio PP, Haber E, Bailey J. On the roles of policies in computer systems management International Journal of Human Computer Studies. 69: 351-361. DOI: 10.1016/j.ijhcs.2011.01.004  1
2011 Aposporidis A, Haber E, Olshanskii MA, Veneziani A. A mixed formulation of the Bingham fluid flow problem: Analysis and numerical solution Computer Methods in Applied Mechanics and Engineering. 200: 2434-2446. DOI: 10.1016/J.Cma.2011.04.004  1
2011 Benzi M, Haber E, Taralli L. A preconditioning technique for a class of PDE-constrained optimization problems Advances in Computational Mathematics. 35: 149-173. DOI: 10.1007/S10444-011-9173-8  1
2010 Faber TL, Santana CA, Piccinelli M, Nye JA, Votaw JR, Garcia EV, Haber E. Automatic Alignment of Myocardial Perfusion Images with Contrast Cardiac Tomography. Ieee Nuclear Science Symposium Conference Record. Nuclear Science Symposium. 2010: 2996-2997. PMID 21892259 DOI: 10.1109/NSSMIC.2010.5874346  1
2010 Haber E, Rehman T, Tannenbaum A. AN EFFICIENT NUMERICAL METHOD FOR THE SOLUTION OF THE L(2) OPTIMAL MASS TRANSFER PROBLEM. Siam Journal On Scientific Computing : a Publication of the Society For Industrial and Applied Mathematics. 32: 197-211. PMID 21278828 DOI: 10.1137/080730238  1
2010 Soares CN, Frey BN, Haber E, Steiner M. A pilot, 8-week, placebo lead-in trial of quetiapine extended release for depression in midlife women: impact on mood and menopause-related symptoms. Journal of Clinical Psychopharmacology. 30: 612-5. PMID 20814317 DOI: 10.1097/Jcp.0B013E3181F1D0F2  1
2010 Haber E, Afergan E, Epstein H, Gutman D, Koroukhov N, Ben-David M, Schachter M, Golomb G. Route of administration-dependent anti-inflammatory effect of liposomal alendronate. Journal of Controlled Release : Official Journal of the Controlled Release Society. 148: 226-33. PMID 20813142 DOI: 10.1016/j.jconrel.2010.08.030  1
2010 Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Experimental Neurology. 224: 472-85. PMID 20546729 DOI: 10.1016/j.expneurol.2010.05.010  1
2010 Haber EM, Kandogan E, Maglio P. For sysadmins, solving problems usually involves collaborating with others. How can we make it more effective? Queue. 8: 1-11. DOI: 10.1145/1898147.1898149  1
2010 Kolesov I, Karasev P, Tannenbaum A, Haber E. Fire and smoke detection in video with optimal mass transport based optical flow and neural networks Proceedings - International Conference On Image Processing, Icip. 761-764. DOI: 10.1109/ICIP.2010.5652119  1
2010 Haber E, Horesh L, Tenorio L. Numerical methods for the design of large-scale nonlinear discrete ill-posed inverse problems Inverse Problems. 26. DOI: 10.1088/0266-5611/26/2/025002  1
2010 Cypher A, Drews C, Haber E, Kandogan E, Lin J, Lau T, Leshed G, Matthews T, Wilcox E. Collaborative scripting for the Web No Code Required. 85-104. DOI: 10.1016/B978-0-12-381541-5.00005-5  1
2010 Haber E, Horesh R, Modersitzki J. Numerical optimization for constrained image registration Numerical Linear Algebra With Applications. 17: 343-359. DOI: 10.1002/Nla.715  1
2010 Hamilton S, Benzi M, Haber E. New multigrid smoothers for the Oseen problem Numerical Linear Algebra With Applications. 17: 557-576. DOI: 10.1002/Nla.707  1
2010 Horesh L, Haber E, Tenorio L. Optimal Experimental Design for the Large-Scale Nonlinear Ill-Posed Problem of Impedance Imaging Large-Scale Inverse Problems and Quantification of Uncertainty. 273-290. DOI: 10.1002/9780470685853.ch13  1
2010 Haber E, Słowińska-Lisowska M, Jóźkow P, Łaczmański Ł, Mȩdraş M. Relationships between the G861C polymorphism of the 5-HT1B serotonin receptor gene and the physical activity in men Advances in Clinical and Experimental Medicine. 19: 455-459.  1
2009 Ur Rehman T, Haber E, Pryor G, Melonakos J, Tannenbaum A. 3D nonrigid registration via optimal mass transport on the GPU. Medical Image Analysis. 13: 931-40. PMID 19135403 DOI: 10.1016/J.Media.2008.10.008  1
2009 Haber E, Danenberg HD, Koroukhov N, Ron-El R, Golomb G, Schachter M. Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Human Reproduction (Oxford, England). 24: 398-407. PMID 18948309 DOI: 10.1093/humrep/den375  1
2009 Haber E. The stylistic role of the anticipatory genitive construction in Sumerian literature Revue D'Assyriologie Et D'Archeologie Orientale. 103: 37-47. DOI: 10.3917/assy.103.0037  1
2009 Kandogan E, Maglio PP, Haber EM, Bailey JH. Scripting practices in complex systems management Chimit 09 - Symposium On Computer-Human Interaction For Management of Information Technology. 9-18. DOI: 10.1145/1641587.1641589  1
2009 Benz M, Haber E, Taralli L. Multilevel algorithms for large-scale interior point methods Siam Journal On Scientific Computing. 31: 4152-4175. DOI: 10.1137/060650799  1
2009 Horesh L, Haber E. Sensitivity computation of the ℓ1 minimization problem and its application to dictionary design of ill-posed problems Inverse Problems. 25. DOI: 10.1088/0266-5611/25/9/095009  1
2009 Haber E, Heldmann S, Modersitzki J. A computational framework for image-based constrained registration Linear Algebra and Its Applications. 431: 459-470. DOI: 10.1016/J.Laa.2009.03.020  1
2009 Kandogan E, Haber EM, Bailey JH, Maglio PP. Studying reactive, risky, complex, long-spanning, and collaborative work: The case of IT service delivery Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 5613: 504-513. DOI: 10.1007/978-3-642-02583-9_55  1
2009 Haber E, Heldmann S, Modersitzki J. A scale-space approach to landmark constrained image registration Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 5567: 612-623. DOI: 10.1007/978-3-642-02256-2_51  1
2009 Haber E, Lutters W, Lucas W, Jain J, Hawkey K. CHIMIT 09 - Symposium on Computer-Human Interaction for Management of Information Technology: Forward Chimit 09 - Symposium On Computer-Human Interaction For Management of Information Technology 1
2009 Haber E. Primat der stabilität Internationale Politik. 64: 83-89.  1
2008 Rehman T, Haber E, Pohl KM, Haker S, Halle M, Talos F, Wald LL, Kikinis R, Tannenbaum A. Multimodal Registration of White Matter Brain Data via Optimal Mass Transport. Midas Journal. 2008: 27-35. PMID 28626844  1
2008 Epstein H, Gutman D, Cohen-Sela E, Haber E, Elmalak O, Koroukhov N, Danenberg HD, Golomb G. Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization. The Aaps Journal. 10: 505-15. PMID 18937071 DOI: 10.1208/s12248-008-9060-5  1
2008 Warwar N, Dov A, Abramovitch E, Wu R, Jmoudiak M, Haber E, Cerasi E, Nesher R. PKCepsilon mediates glucose-regulated insulin production in pancreatic beta-cells. Biochimica Et Biophysica Acta. 1783: 1929-34. PMID 18486624 DOI: 10.1016/j.bbamcr.2008.04.007  1
2008 Gopisetty S, Agarwala S, Butler E, Jadav D, Jaquet S, Korupolu M, Routray R, Sarkar P, Singh A, Sivan-Zimet M, Tan CH, Uttamchandani S, Merbach D, Padbidri S, Dieberger A, ... Haber EM, et al. Evolution of storage management: Transforming raw data into information Ibm Journal of Research and Development. 52: 341-352. DOI: 10.1147/rd.524.0341  1
2008 Leshed G, Haber EM, Matthews T, Lau T. CoScripter: Automating & sharing how-to knowledge in the enterprise Conference On Human Factors in Computing Systems - Proceedings. 1719-1728. DOI: 10.1145/1357054.1357323  1
2008 Haber E, Heldmann S, Modersitzki J. Adaptive mesh refinement for nonparametric image registration Siam Journal On Scientific Computing. 30: 3012-3027. DOI: 10.1137/070687724  1
2008 Haber E, Horesh L, Tenorio L. Numerical methods for experimental design of large-scale linear ill-posed inverse problems Inverse Problems. 24. DOI: 10.1088/0266-5611/24/5/055012  1
2008 Schumacher H, Heldmann S, Haber E, Fischer B. Iterative reconstruction of SPECT images using adaptive multi-level refinement Informatik Aktuell. 318-322.  1
2008 Haber E. Knowledge is power in selecting audio DACs Electronic Products (Garden City, New York). 50.  1
2007 Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR, Curi R. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. The Journal of Physiology. 583: 9-24. PMID 17584843 DOI: 10.1113/jphysiol.2007.135871  1
2007 Haber E, Modersitzki J. Intensity gradient based registration and fusion of multi-modal images. Methods of Information in Medicine. 46: 292-9. PMID 17492115 DOI: 10.1160/Me9046  1
2006 Haber E, Modersitzki J. Intensity gradient based registration and fusion of multi-modal images. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 9: 726-33. PMID 17354837  1
2006 Warwar N, Efendic S, Ostenson CG, Haber EP, Cerasi E, Nesher R. Dynamics of glucose-induced localization of PKC isoenzymes in pancreatic beta-cells: diabetes-related changes in the GK rat. Diabetes. 55: 590-9. PMID 16505220  1
2006 Haber EP, Procópio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R. New insights into fatty acid modulation of pancreatic beta-cell function. International Review of Cytology. 248: 1-41. PMID 16487789 DOI: 10.1016/S0074-7696(06)48001-3  1
2005 Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER. Binding of immunogenic peptides to Ia histocompatibility molecules. 1985. Journal of Immunology (Baltimore, Md. : 1950). 175: 4163-5. PMID 16177052  1
2005 Potikha T, Kassem S, Haber EP, Ariel I, Glaser B. p57Kip2 (cdkn1c): sequence, splice variants and unique temporal and spatial expression pattern in the rat pancreas. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 364-75. PMID 15696192 DOI: 10.1038/Labinvest.3700229  1
2003 Haber EP, Hirabara SM, Gomes AD, Curi R, Carpinelli AR, Carvalho CR. Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets. Febs Letters. 544: 185-8. PMID 12782313  1
2003 Haber EP, Ximenes HM, Procópio J, Carvalho CR, Curi R, Carpinelli AR. Pleiotropic effects of fatty acids on pancreatic beta-cells. Journal of Cellular Physiology. 194: 1-12. PMID 12447984 DOI: 10.1002/jcp.10187  1
2002 Picinato MC, Haber EP, Carpinelli AR, Cipolla-Neto J. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. Journal of Pineal Research. 33: 172-7. PMID 12220333  1
2002 Picinato MC, Haber EP, Cipolla-Neto J, Curi R, de Oliveira Carvalho CR, Carpinelli AR. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. Journal of Pineal Research. 33: 156-60. PMID 12220330  1
2001 Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, Storch J, Feinberg MW, Hsieh CM, Haber E, Lee ME. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1774-6. PMID 11481226 DOI: 10.1096/Fj.01-0017Fje  1
2001 Haber E, Muñoz-Guerra JA, Soriano C, Carreras D, Rodriguez C, Rodriguez FA. Automated sample preparation and gas chromatographic-mass spectrometric analysis of urinary androgenic anabolic steroids. Journal of Chromatography. B, Biomedical Sciences and Applications. 755: 17-26. PMID 11393702 DOI: 10.1016/S0378-4347(00)00539-9  1
1999 Gliner JA, Haber E, Weise J. Use of controlled vignettes in evaluation: does type of response method make a difference? Evaluation and Program Planning. 22: 313-22. PMID 24011451  1
1999 Huggins GS, Chin MT, Sibinga NE, Lee SL, Haber E, Lee ME. Characterization of the mUBC9-binding sites required for E2A protein degradation. The Journal of Biological Chemistry. 274: 28690-6. PMID 10497239 DOI: 10.1074/Jbc.274.40.28690  1
1999 Shi C, Patel A, Zhang D, Wang H, Carmeliet P, Reed GL, Lee ME, Haber E, Sibinga NE. Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. Circulation Research. 84: 883-90. PMID 10222334 DOI: 10.1161/01.Res.84.8.883  1
1999 Sibinga NE, Wang H, Perrella MA, Endege WO, Patterson C, Yoshizumi M, Haber E, Lee ME. Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter. The Journal of Biological Chemistry. 274: 12139-46. PMID 10207041 DOI: 10.1074/Jbc.274.17.12139  1
1999 Shi C, Feinberg MW, Zhang D, Patel A, Sim CU, Dong ZM, Chapman SM, Gutierrez-Ramos JC, Wagner DD, Sibinga NE, Haber E. Donor MHC and adhesion molecules in transplant arteriosclerosis. The Journal of Clinical Investigation. 103: 469-74. PMID 10021454 DOI: 10.1172/Jci4584  1
1998 Moons L, Shi C, Ploplis V, Plow E, Haber E, Collen D, Carmeliet P. Reduced transplant arteriosclerosis in plasminogen-deficient mice. The Journal of Clinical Investigation. 102: 1788-97. PMID 9819364 DOI: 10.1172/Jci3316  1
1998 Jain MK, Kashiki S, Hsieh CM, Layne MD, Yet SF, Sibinga NE, Chin MT, Feinberg MW, Woo I, Maas RL, Haber E, Lee ME. Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. Circulation Research. 83: 980-5. PMID 9815145 DOI: 10.1161/01.Res.83.10.980  1
1998 Foster LC, Arkonac BM, Sibinga NE, Shi C, Perrella MA, Haber E. Regulation of CD44 gene expression by the proinflammatory cytokine interleukin-1beta in vascular smooth muscle cells. The Journal of Biological Chemistry. 273: 20341-6. PMID 9685385 DOI: 10.1074/Jbc.273.32.20341  1
1998 Layne MD, Endege WO, Jain MK, Yet SF, Hsieh CM, Chin MT, Perrella MA, Blanar MA, Haber E, Lee ME. Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation. The Journal of Biological Chemistry. 273: 15654-60. PMID 9624159 DOI: 10.1074/Jbc.273.25.15654  1
1998 Lee WS, Jain MK, Arkonac BM, Zhang D, Shaw SY, Kashiki S, Maemura K, Lee SL, Hollenberg NK, Lee ME, Haber E. Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circulation Research. 82: 845-51. PMID 9576104 DOI: 10.1161/01.Res.82.8.845  1
1998 Arkonac BM, Foster LC, Sibinga NE, Patterson C, Lai K, Tsai JC, Lee ME, Perrella MA, Haber E. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. The Journal of Biological Chemistry. 273: 4400-5. PMID 9468491 DOI: 10.1074/Jbc.273.8.4400  1
1998 Shi C, Sibinga NES, Lee AM, Haber E. Studies in Transplant Arteriosclerosis Using Gene Deletions Journal of Vascular and Interventional Radiology. 9: 691-693. DOI: 10.1016/S1051-0443(98)70361-6  1
1997 Haber E, Shi C. The role of specific genes in transplant arteriosclerosis: studies in mutant mice. Transplant Immunology. 5: 293-7. PMID 9504150 DOI: 10.1016/S0966-3274(97)80011-1  1
1997 Shi C, Lee WS, Russell ME, Zhang D, Fletcher DL, Newell JB, Haber E. Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice. Circulation. 96: 2722-8. PMID 9355915 DOI: 10.1161/01.Cir.96.8.2722  1
1997 Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, Lee ME. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. The Journal of Biological Chemistry. 272: 25380-5. PMID 9312159 DOI: 10.1074/Jbc.272.40.25380  1
1997 Lee WS, Harder JA, Yoshizumi M, Lee ME, Haber E. Progesterone inhibits arterial smooth muscle cell proliferation. Nature Medicine. 3: 1005-8. PMID 9288727 DOI: 10.1038/Nm0997-1005  1
1997 Kho CJ, Huggins GS, Endege WO, Patterson C, Jain MK, Lee ME, Haber E. The polymyositis-scleroderma autoantigen interacts with the helix-loop-helix proteins E12 and E47. The Journal of Biological Chemistry. 272: 13426-31. PMID 9148967 DOI: 10.1074/Jbc.272.20.13426  1
1997 Sibinga NE, Foster LC, Hsieh CM, Perrella MA, Lee WS, Endege WO, Sage EH, Lee ME, Haber E. Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circulation Research. 80: 532-41. PMID 9118484 DOI: 10.1161/01.Res.80.4.532  1
1997 Patterson C, Wu Y, Lee ME, DeVault JD, Runge MS, Haber E. Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. Regulation of Sp1 binding is associated with cell type-specific expression. The Journal of Biological Chemistry. 272: 8410-6. PMID 9079666 DOI: 10.1074/Jbc.272.13.8410  1
1997 Bode C, Hanson SR, Schmedtje JF, Haber E, Mehwald P, Kelly AB, Harker LA, Runge MS. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. Circulation. 95: 800-4. PMID 9054733 DOI: 10.1161/01.Cir.95.4.800  1
1997 Kho CJ, Huggins GS, Endege WO, Hsieh CM, Lee ME, Haber E. Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A. The Journal of Biological Chemistry. 272: 3845-51. PMID 9013644 DOI: 10.1074/Jbc.272.6.3845  1
1997 Moons L, Shi S, Ploplis V, Plow E, Haber E, Collen D, Carmeliet P. 76 Reduced transplant arteriosclerosis in plasminogen deficient mice Fibrinolysis and Proteolysis. 11: 22. DOI: 10.1016/S0268-9499(97)80192-0  1
1996 George A, Huston JS, Haber E. Exploring and exploiting the antibody and Ig superfamily combining sites. Nature Biotechnology. 14: 584. PMID 9630946 DOI: 10.1038/Nbt0596-584  1
1996 Haber E. Industry and the university. Nature Biotechnology. 14: 441-2. PMID 9630917 DOI: 10.1038/Nbt0496-441  0.01
1996 Huston JS, Haber E. An overview of the 1996 Keystone meeting. Exploring and exploiting antibody and Ig superfamily combining sites. Immunotechnology : An International Journal of Immunological Engineering. 2: 253-60. PMID 9373307 DOI: 10.1016/S1380-2933(96)00052-8  1
1996 Haber E. Can a viral serine proteinase inhibitor prevent postangioplasty restenosis? Circulation. 94: 2694-5. PMID 8941089 DOI: 10.1161/01.Cir.94.11.2694  0.01
1996 Huston JS, Margolies MN, Haber E. Antibody binding sites. Advances in Protein Chemistry. 49: 329-450. PMID 8908302 DOI: 10.1016/S0065-3233(08)60493-3  1
1996 Narula J, Khaw BA, Dec GW, Palacios IF, Newell JB, Southern JF, Fallon JT, Strauss HW, Haber E, Yasuda T. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 3: 371-81. PMID 8902668 DOI: 10.1016/S1071-3581(96)90070-7  1
1996 Lai K, Wang H, Lee WS, Jain MK, Lee ME, Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. The Journal of Clinical Investigation. 98: 1560-7. PMID 8833904 DOI: 10.1172/Jci118949  1
1996 Runge MS, Harker LA, Bode C, Ruef J, Kelly AB, Marzec UM, Allen E, Caban R, Shaw SY, Haber E, Hanson SR. Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation. 94: 1412-22. PMID 8823001 DOI: 10.1161/01.Cir.94.6.1412  1
1996 Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee ME, Haber E. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. The Journal of Clinical Investigation. 98: 490-6. PMID 8755661 DOI: 10.1172/Jci118816  1
1996 Perrella MA, Hsieh CM, Lee WS, Shieh S, Tsai JC, Patterson C, Lowenstein CJ, Long NC, Haber E, Shore S, Lee ME. Arrest of endotoxin-induced hypotension by transforming growth factor beta1. Proceedings of the National Academy of Sciences of the United States of America. 93: 2054-9. PMID 8700884 DOI: 10.1073/Pnas.93.5.2054  1
1996 Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. The Journal of Clinical Investigation. 98: 877. PMID 8698880  1
1996 Shi C, Lee WS, He Q, Zhang D, Fletcher DL, Newell JB, Haber E. Immunologic basis of transplant-associated arteriosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 93: 4051-6. PMID 8633015 DOI: 10.1073/Pnas.93.9.4051  1
1996 Tsai JC, Jain M, Hsieh CM, Lee WS, Yoshizumi M, Patterson C, Perrella MA, Cooke C, Wang H, Haber E, Schlegel R, Lee ME. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. The Journal of Biological Chemistry. 271: 3667-70. PMID 8631978 DOI: 10.1074/Jbc.271.7.3667  1
1996 Jain MK, Fujita KP, Hsieh CM, Endege WO, Sibinga NE, Yet SF, Kashiki S, Lee WS, Perrella MA, Haber E, Lee ME. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. The Journal of Biological Chemistry. 271: 10194-9. PMID 8626582 DOI: 10.1074/Jbc.271.17.10194  1
1996 Campan M, Yoshizumi M, Seidah NG, Lee ME, Bianchi C, Haber E. Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry. 35: 3797-802. PMID 8620001 DOI: 10.1021/Bi952552D  1
1996 Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. The Journal of Clinical Investigation. 97: 596-603. PMID 8609213 DOI: 10.1172/Jci118455  1
1996 Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NE, Tan LC, Haber E, Chang TH, Schlegel R, Lee ME. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. The Journal of Clinical Investigation. 97: 146-53. PMID 8550827 DOI: 10.1172/Jci118383  1
1995 Haber E. Angiotensin-converting enzyme and lipoprotein(a) as risk factors for myocardial infarction. Circulation. 91: 1888-90. PMID 7882501 DOI: 10.1161/01.Cir.91.6.1888  0.01
1995 Patterson C, Perrella MA, Hsieh CM, Yoshizumi M, Lee ME, Haber E. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. The Journal of Biological Chemistry. 270: 23111-8. PMID 7559454 DOI: 10.1074/Jbc.270.39.23111  1
1995 Haber E. New fibrinolytic agents — Future developments Fibrinolysis and Proteolysis. 9: 100-103. DOI: 10.1016/S0268-9499(08)80022-7  0.01
1994 Schildbach JF, Shaw SY, Bruccoleri RE, Haber E, Herzenberg LA, Jager GC, Jeffrey PD, Panka DJ, Parks DR, Near RI. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody. Protein Science : a Publication of the Protein Society. 3: 737-49. PMID 8061604 DOI: 10.1002/Pro.5560030503  1
1994 Shi C, Russell ME, Bianchi C, Newell JB, Haber E. Murine model of accelerated transplant arteriosclerosis. Circulation Research. 75: 199-207. PMID 8033333 DOI: 10.1161/01.Res.75.2.199  1
1994 Zusman RM, Hui KY, Nussberger J, Christensen DM, Higgins J, Carlson WD, Schoenfeld D, Haber E. R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers. American Journal of Hypertension. 7: 295-301. PMID 8031544 DOI: 10.1093/Ajh/7.4.295  1
1994 Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 91: 6369-73. PMID 8022789 DOI: 10.1073/Pnas.91.14.6369  1
1994 Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin. Circulation. 90: 1956-63. PMID 7923685 DOI: 10.1161/01.Cir.90.4.1956  1
1994 Haber E, Lee ME. Cardiac physiology. Endothelin to the rescue? Nature. 370: 252-3. PMID 7518570 DOI: 10.1038/370252A0  1
1994 Love TW, Quertermous T, Runge MS, Michelson KD, Matsueda GR, Haber E. Attachment of an antifibrin antibody to the amino terminus of tissue-type plasminogen activator impairs stimulation by Fibrin Fibrinolysis and Proteolysis. 8: 326-332. DOI: 10.1016/0268-9499(94)90022-1  1
1993 Haber E. The impact of biotechnology on advances in cardiovascular medicine. Trends in Cardiovascular Medicine. 3: 207-12. PMID 21244910 DOI: 10.1016/1050-1738(93)90041-4  0.01
1993 Loike JD, Silverstein R, Cao L, Solomon L, Weitz J, Haber E, Matsueda GR, Bernatowicz MS, Silverstein SC. Activated platelets form protected zones of adhesion on fibrinogen and fibronectin-coated surfaces. The Journal of Cell Biology. 121: 945-55. PMID 8491785 DOI: 10.1083/Jcb.121.4.945  1
1993 Love TW, Quertermous T, Zavodny PJ, Runge MS, Chou CC, Mullins D, Huang PL, Schnee JM, Kestin AS, Savard CE. High-level expression of antibody-plasminogen activator fusion proteins in hybridoma cells. Thrombosis Research. 69: 221-9. PMID 8446952 DOI: 10.1016/0049-3848(93)90047-R  1
1993 Schillbach JF, Near RI, Bruccoleri RE, Haber E, Jeffrey PD, Novotny J, Sheriff S, Margolies MN. Modulation of antibody affinity by a non-contact residue. Protein Science : a Publication of the Protein Society. 2: 206-14. PMID 8443598 DOI: 10.1002/Pro.5560020209  1
1993 Narula J, Khaw BA, Dec GW, Palacios IF, Southern JF, Fallon JT, Strauss HW, Haber E, Yasuda T. Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. The New England Journal of Medicine. 328: 100-4. PMID 8416421 DOI: 10.1056/Nejm199301143280205  1
1993 Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, Lo LC, Berova N, Nakanishi K, Haber E. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proceedings of the National Academy of Sciences of the United States of America. 90: 8189-93. PMID 8396262 DOI: 10.1073/Pnas.90.17.8189  1
1993 Nicol PD, Matsueda GR, Haber E, Khaw BA. Synthetic peptide immunogens for the development of a cardiac myosin light chain-1 specific radioimmunoassay. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 34: 2144-51. PMID 8254402  1
1993 Jeffrey PD, Strong RK, Sieker LC, Chang CY, Campbell RL, Petsko GA, Haber E, Margolies MN, Sheriff S. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. Proceedings of the National Academy of Sciences of the United States of America. 90: 10310-4. PMID 8234291 DOI: 10.1073/Pnas.90.21.10310  1
1993 Schildbach JF, Near RI, Bruccoleri RE, Haber E, Jeffrey PD, Ng SC, Novotny J, Sheriff S, Margolies MN. Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10. The Journal of Biological Chemistry. 268: 21739-47. PMID 7691815  1
1992 Isobe M, Narula J, Southern JF, Strauss HW, Khaw BA, Haber E. Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction. Circulation. 85: 738-46. PMID 1735166 DOI: 10.1161/01.Cir.85.2.738  1
1992 Anthony J, Near R, Wong SL, Iida E, Ernst E, Wittekind M, Haber E, Ng SC. Production of stable anti-digoxin Fv in Escherichia coli. Molecular Immunology. 29: 1237-47. PMID 1528194 DOI: 10.1016/0161-5890(92)90060-B  1
1992 Hui KY, Siragy HM, Haber E. Design of potent substrate-analogue inhibitors of canine renin. International Journal of Peptide and Protein Research. 40: 152-60. PMID 1446972 DOI: 10.1111/J.1399-3011.1992.Tb01464.X  1
1992 Bode C, Runge MS, Haber E. Purifying antibody-plasminogen activator conjugates. Bioconjugate Chemistry. 3: 269-72. PMID 1390979 DOI: 10.1021/Bc00016A001  1
1992 Chen F, Haber E, Matsueda GR. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products. Thrombosis and Haemostasis. 67: 335-40. PMID 1379385 DOI: 10.1055/S-0038-1648443  1
1992 Haber E, Bode C, Matsueda GR, Reed GL, Runge MS. Antibody targeting as a thrombolytic strategy. Annals of the New York Academy of Sciences. 667: 365-81. PMID 1309057 DOI: 10.1111/J.1749-6632.1992.Tb51637.X  1
1992 Haber E. Engineered antibodies as pharmacological tools. Immunological Reviews. 130: 189-212. PMID 1286870 DOI: 10.1111/J.1600-065X.1992.Tb01526.X  0.01
1992 Reed GL, Matsueda GR, Haber E. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin. Thrombosis and Haemostasis. 68: 315-20. PMID 1279832 DOI: 10.1055/S-0038-1656372  1
1991 Runge MS, Haber E. Importance of experimental models in study of thrombosis and thrombolysis. Circulation. 83: IV1-2. PMID 2040067  1
1991 Schildbach JF, Panka DJ, Parks DR, Jager GC, Novotny J, Herzenberg LA, Mudgett-Hunter M, Bruccoleri RE, Haber E, Margolies MN. Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutations. The Journal of Biological Chemistry. 266: 4640-7. PMID 1999439  1
1991 Haber EC. Osgood-Schlatter disease. American Family Physician. 43: 400, 402, 405. PMID 1990728  0.01
1991 Isobe M, Haber E, Khaw BA. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts. Circulation. 84: 1246-55. PMID 1884451 DOI: 10.1161/01.Cir.84.3.1246  1
1991 Bode C, Meinhardt G, Runge MS, Freitag M, Nordt T, Arens M, Newell JB, Kübler W, Haber E. Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation. Circulation. 84: 805-13. PMID 1860223 DOI: 10.1161/01.Cir.84.2.805  1
1991 Bode C, Nordt T, Detlefs-Bartels U, Runge MS, Arens M, Kübler W, Haber E. Targeting of single-chain urokinase plasminogen activator by conjugation to an antiplatelet antibody results in enhanced clot lysis. Transactions of the Association of American Physicians. 104: 29-31. PMID 1845154  1
1991 Reed GL, Matsueda GR, Haber E. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis. Transactions of the Association of American Physicians. 104: 21-8. PMID 1845147  1
1991 Bode C, Nordt T, Freitag M, Ruef J, Kaltenmeier M, Meinhardt G, Kübler W, Haber E. [Increased thrombolysis and decreased platelet aggregation with an anti-GPIIb/IIIa antibody urokinase hybrid molecule (7E3-UK)]. Verhandlungen Der Deutschen Gesellschaft Fã¼R Innere Medizin. 97: 1-2. PMID 1839701  1
1991 Runge MS, Bode C, Haber E, Quertermous T. Hybrid molecules: insights into plasminogen activator function. Molecular Biology & Medicine. 8: 245-55. PMID 1806766  1
1991 Huston JS, Mudgett-Hunter M, Tai MS, McCartney J, Warren F, Haber E, Oppermann H. Protein engineering of single-chain Fv analogs and fusion proteins. Methods in Enzymology. 203: 46-88. PMID 1762568 DOI: 10.1016/0076-6879(91)03005-2  1
1991 Lukacova D, Matsueda GR, Haber E, Reed GL. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody. Biochemistry. 30: 10164-70. PMID 1681898 DOI: 10.1021/Bi00106A013  1
1991 Narula J, Yasuda T, Southern JF, Khaw BA, Palacios IF, Newell JB, Dec GW, Fallon JT, Strauss HW, Haber E. Antimyosin scintigraphy in myocarditis: Evaluation of diagnostic methodology Journal of the American College of Cardiology. 17. DOI: 10.1016/0735-1097(91)92333-H  1
1991 Isobe M, Haber E, Khaw BA. Class 1 major histocompatibility antigen modified with monomethoxy polyethylene glycol prolongs survival of cardiac allografts in mice Journal of the American College of Cardiology. 17. DOI: 10.1016/0735-1097(91)92327-I  1
1990 Dec GW, Palacios I, Yasuda T, Fallon JT, Khaw BA, Strauss HW, Haber E. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. Journal of the American College of Cardiology. 16: 97-104. PMID 2358612 DOI: 10.1016/0735-1097(90)90463-Y  1
1990 Novotny J, Bruccoleri RE, Haber E. Computer analysis of mutations that affect antibody specificity. Proteins. 7: 93-8. PMID 2330371 DOI: 10.1002/prot.340070109  1
1990 Tai MS, Mudgett-Hunter M, Levinson D, Wu GM, Haber E, Oppermann H, Huston JS. A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry. 29: 8024-30. PMID 2261460 DOI: 10.1021/Bi00487A005  1
1990 Haber E, Quertermous T, Matsueda GR, Runge MS, Bode C. Antibody-targeted thrombolytic agents. Japanese Circulation Journal. 54: 345-53. PMID 2204740 DOI: 10.1253/Jcj.54.345  1
1990 Bode C, Runge MS, Haber E. Future directions in plasminogen activator therapy. Clinical Cardiology. 13: 375-81. PMID 2188764 DOI: 10.1002/Clc.4960130602  1
1990 Antman EM, Wenger TL, Butler VP, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 81: 1744-52. PMID 2188752 DOI: 10.1161/01.Cir.81.6.1744  1
1990 Runge MS, Bode C, Savard CE, Matsueda GR, Haber E. Antibody-directed fibrinolysis: a bispecific (Fab')2 that binds to fibrin and tissue plasminogen activator. Bioconjugate Chemistry. 1: 274-7. PMID 2129015 DOI: 10.1021/Bc00004A008  1
1990 Bode C, Eberle T, Runge M, Haber E, Kübler W. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo]. Verhandlungen Der Deutschen Gesellschaft Fã¼R Innere Medizin. 96: 1-3. PMID 2128723  1
1990 Branscomb EE, Runge MS, Savard CE, Adams KM, Matsueda GR, Haber E. Bispecific monoclonal antibodies produced by somatic cell fusion increase the potency of tissue plasminogen activator. Thrombosis and Haemostasis. 64: 260-6. PMID 2125375 DOI: 10.1055/S-0038-1647297  1
1990 Haber E. Can plasminogen activators be improved? Circulation. 82: 1874-6. PMID 2121386  0.01
1990 Near RI, Ng SC, Mudgett-Hunter M, Hudson NW, Margolies MN, Seidman JG, Haber E, Jacobson MA. Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes. Molecular Immunology. 27: 901-9. PMID 2120577 DOI: 10.1016/0161-5890(90)90157-U  1
1990 Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator. Circulation. 81: 1974-80. PMID 2111744 DOI: 10.1161/01.Cir.81.6.1974  1
1990 Russell ME, Quertermous T, Declerck PJ, Collen D, Haber E, Homcy CJ. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1. The Journal of Biological Chemistry. 265: 2569-75. PMID 2105930  1
1990 Charpie JR, Runge MS, Matsueda GR, Haber E. A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase. Biochemistry. 29: 6374-8. PMID 1698452 DOI: 10.1021/Bi00479A005  1
1990 Reed GL, Matsueda GR, Haber E. Inhibition of clot-bound alpha 2-antiplasmin enhances in vivo thrombolysis. Circulation. 82: 164-8. PMID 1694738 DOI: 10.1161/01.Cir.82.1.164  1
1990 Reed GL, Matsueda GR, Haber E. Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin. Proceedings of the National Academy of Sciences of the United States of America. 87: 1114-8. PMID 1689060 DOI: 10.1073/Pnas.87.3.1114  1
1989 Rezkalla S, Kloner RA, Khaw BA, Haber E, Fallon JT, Smith FE, Khatib R. Detection of experimental myocarditis by monoclonal antimyosin antibody, Fab fragment. American Heart Journal. 117: 391-5. PMID 2916411 DOI: 10.1016/0002-8703(89)90785-0  1
1989 Khaw BA, Torchilin VP, Klibanov AL, Nossiff ND, Powers JB, Strauss HW, Haber E. Modification of monoclonal antimyosin antibody: enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarction. Journal of Molecular and Cellular Cardiology. 21: 31-5. PMID 2733028 DOI: 10.1016/0022-2828(89)90835-3  1
1989 Bode C, Runge MS, Haber E. Improving on nature: antibody-targeted enzymes. The Year in Immunology. 6: 185-96. PMID 2701902  1
1989 Hui KY, Knight DR, Nussberger J, Hartley LH, Vatner SF, Haber E. Effects of renin inhibition in the conscious primate Macaca fascicularis. Hypertension. 14: 480-7. PMID 2680962  1
1989 Haber E. Why renin inhibitors? Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 7: S81-6. PMID 2666619  0.01
1989 Runge MS, Quertermous T, Haber E. Plasminogen activators. The old and the new. Circulation. 79: 217-24. PMID 2644053 DOI: 10.1161/01.Cir.79.2.217  1
1989 Khaw BA, Haber E. Imaging necrotic myocardium: detection with 99mTc-pyrophosphate and radiolabeled antimyosin. Cardiology Clinics. 7: 577-88. PMID 2548722 DOI: 10.1016/S0733-8651(18)30419-3  1
1989 Bode C, Runge M, Eberle T, Freitag M, Kübler W, Haber E. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody. Transactions of the Association of American Physicians. 102: 7-12. PMID 2517856  1
1989 Love TW, Runge MS, Haber E, Quertermous T. Recombinant antibodies possessing novel effector functions. Methods in Enzymology. 178: 515-27. PMID 2513468 DOI: 10.1016/0076-6879(89)78037-X  1
1989 Near RI, Haber E. Characterization of the heavy and light chain immunoglobulin variable region genes used in a set of anti-digoxin antibodies. Molecular Immunology. 26: 371-82. PMID 2497340 DOI: 10.1016/0161-5890(89)90126-0  1
1989 Haber E, Quertermous T, Matsueda GR, Runge MS. Innovative approaches to plasminogen activator therapy. Science (New York, N.Y.). 243: 51-6. PMID 2492113 DOI: 10.1126/Science.2492113  1
1989 Bode C, Runge MS, Branscomb EE, Newell JB, Matsueda GR, Haber E. Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activator. The Journal of Biological Chemistry. 264: 944-8. PMID 2492021  1
1988 Bruccoleri RE, Haber E, Novotný J. Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature. 335: 564-8. PMID 3419534 DOI: 10.1038/335564A0  1
1988 Charpie JR, Haber E, Matsueda GR. A sequence-dependent monoclonal antibody specific for single-chain urokinase. Biochemical and Biophysical Research Communications. 152: 910-5. PMID 3365258 DOI: 10.1016/S0006-291X(88)80126-8  1
1988 Runge MS, Quertermous T, Matsueda GR, Haber E. Increasing selectivity of plasminogen activators with antibodies. Clinical Research. 36: 501-6. PMID 3139350  1
1988 Runge MS, Bode C, Matsueda GR, Haber E. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro. Biochemistry. 27: 1153-7. PMID 3130094 DOI: 10.1021/Bi00404A012  1
1988 Panka DJ, Mudgett-Hunter M, Parks DR, Peterson LL, Herzenberg LA, Haber E, Margolies MN. Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies. Proceedings of the National Academy of Sciences of the United States of America. 85: 3080-4. PMID 3129726 DOI: 10.1073/Pnas.85.9.3080  1
1988 Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotný J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 85: 5879-83. PMID 3045807 DOI: 10.1073/Pnas.85.16.5879  1
1988 Hui KY, Holtzman EJ, Quinones MA, Hollenberg NK, Haber E. Design of rat renin inhibitory peptides. Journal of Medicinal Chemistry. 31: 1679-86. PMID 3045320 DOI: 10.1021/Jm00117A003  1
1988 Reed GL, Matsueda GR, Haber E. Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin. Transactions of the Association of American Physicians. 101: 250-6. PMID 2480017  1
1988 Galen FX, Evin G, Carelli C, Bouhnik J, Michel JB, Ferhentz JA, Le N'Guyen D, Seyer R, Carlson WD, Haber E. [Production and characterization of human antirenin antibodies prepared with synthetic immunogens]. Archives Des Maladies Du Coeur Et Des Vaisseaux. 81: 199-201. PMID 2461182  1
1988 Evin G, Galen FX, Carlson WD, Handschumacher M, Novotný J, Bouhnik J, Ménard J, Corvol P, Haber E. Characterization of five epitopes of human renin from a computer model. Biochemistry. 27: 156-64. PMID 2450565  1
1988 Bruccoleri RE, Haber E, Novotný J. Erratum: Corrigendum: Structure of antibody hypervariable loops reproduced by a conformational search algorithm Nature. 336: 266-266. DOI: 10.1038/336266B0  1
1987 Timmis AD, Lopez JA, Fallon JT, Khaw BA, Haber E, Powell WJ. Detection of early necrosis in a canine model of low flow myocardial ischemia using 125I-antimyosin (Fab')2. Journal of Applied Cardiology. 2: 185-211. PMID 11540157  1
1987 Khaw BA, Yasuda T, Gold HK, Leinbach RC, Johns JA, Kanke M, Barlai-Kovach M, Strauss HW, Haber E. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 28: 1671-8. PMID 3668661  1
1987 Bode C, Runge MS, Newell JB, Matsueda GR, Haber E. Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugate. Journal of Molecular and Cellular Cardiology. 19: 335-41. PMID 3612817 DOI: 10.1016/S0022-2828(87)80578-3  1
1987 Bode C, Runge MS, Newell JB, Matsueda GR, Haber E. Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrin. The Journal of Biological Chemistry. 262: 10819-23. PMID 3611093  1
1987 Yasuda T, Palacios IF, Dec GW, Fallon JT, Gold HK, Leinbach RC, Strauss HW, Khaw BA, Haber E. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation. 76: 306-11. PMID 3608120 DOI: 10.1161/01.Cir.76.2.306  1
1987 Liau CS, Haber E, Matsueda GR. Evaluation of monoclonal antifibrin antibodies by their binding to human blood clots. Thrombosis and Haemostasis. 57: 49-54. PMID 3590080 DOI: 10.1055/S-0038-1651060  1
1987 Hui KY, Carlson WD, Bernatowicz MS, Haber E. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides. Journal of Medicinal Chemistry. 30: 1287-95. PMID 3302256 DOI: 10.1021/Jm00391A005  1
1987 Runge MS, Bode C, Matsueda GR, Haber E. Antibody-enhanced thrombolysis: capture of tissue plasminogen activator by a bispecific antibody and direct targeting by an antifibrin-tissue plasminogen activator conjugate in vivo. Transactions of the Association of American Physicians. 100: 250-5. PMID 3137708  1
1987 Runge MS, Bode C, Matsueda GR, Haber E. Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo. Proceedings of the National Academy of Sciences of the United States of America. 84: 7659-62. PMID 3118374 DOI: 10.1073/Pnas.84.21.7659  1
1987 Schnee JM, Runge MS, Matsueda GR, Hudson NW, Seidman JG, Haber E, Quertermous T. Construction and expression of a recombinant antibody-targeted plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America. 84: 6904-8. PMID 3116546 DOI: 10.1073/Pnas.84.19.6904  1
1987 Torchilin VP, Klibanov AL, Nossiff ND, Slinkin MA, Strauss HW, Haber E, Smirnov VN, Khaw BA. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding. Hybridoma. 6: 229-40. PMID 3110049 DOI: 10.1089/Hyb.1987.6.229  1
1987 Khaw BA, Strauss HW, Moore R, Fallon JT, Yasuda T, Gold HK, Haber E. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 28: 76-82. PMID 3025386  1
1987 Carlson WD, Handschumacher M, Summers N, Karplus M, Haber E. Models for the three-dimensional structure of renin inhibitors bound in the active site of human renin: an analysis of the properties that produce tight binding. Journal of Cardiovascular Pharmacology. 10: S91-3. PMID 2485071 DOI: 10.1097/00005344-198706107-00015  1
1987 Haber E, Hui KY, Carlson WD, Bernatowicz MS. Renin inhibitors: a search for principles of design. Journal of Cardiovascular Pharmacology. 10: S54-8. PMID 2485064 DOI: 10.1097/00005344-198706107-00009  1
1987 Galen FX, Evin G, Carelli C, Bouhnik J, Michel JB, Ferhentz JA, Le N'Guyen D, Seyer R, Carlson WD, Haber E. Production and characterization of human renin antibodies prepared with synthetic immunogens. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 5: S11-4. PMID 2450977  1
1987 Novotny J, Bruccoleri RE, Carlson WD, Handschumacher M, Haber E. Antigenicity of myohemerythrin. Science (New York, N.Y.). 238: 1584-6. PMID 2446393 DOI: 10.1126/Science.2446393  1
1987 Haber E, Haupert GT. The search for a hypothalamic Na+,K+-ATPase inhibitor. Hypertension. 9: 315-24. PMID 2435655  0.01
1987 Haber E, Yasuda T, Palacios IF, Dec GW, Gold HK, Leinbach RC, Fallon JT, Strauss HW, Khaw BA. Antimyosin antibody imaging in the diagnosis of acute myocarditis European Heart Journal. 8: 119-123. DOI: 10.1093/Eurheartj/8.Suppl_J.119  1
1986 Haber EP, Atalla LT. Comparison of ion chromatography and neutron activation analysis for the microdetermination of Na+ and K+ in muscle. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De Biofã­Sica ... [Et Al.]. 19: 103-7. PMID 3801718  0.01
1986 Torchilin VP, Khaw BA, Klibanov AL, Slinkin MA, Haber E. [Modification of monoclonal antibodies by polymers possessing chelating properties]. Biulleten' Eksperimental'Noä­ Biologii I Meditsiny. 102: 63-5. PMID 3730595 DOI: 10.1007/Bf00840001  1
1986 Haber E. The CIBA award for 1985. A full circle in two generations. Hypertension. 8: 469-70. PMID 3519450  0.01
1986 Haber E. In vivo diagnostic and therapeutic uses of monoclonal antibodies in cardiology. Annual Review of Medicine. 37: 249-61. PMID 3518607 DOI: 10.1146/annurev.me.37.020186.001341  0.01
1986 Husby G, Arora R, Williams RC, Khaw BA, Haber E, Butler C. Immunofluorescence studies of florid rheumatic Aschoff lesions. Arthritis and Rheumatism. 29: 207-11. PMID 3513770 DOI: 10.1002/Art.1780290208  1
1986 Dzau VJ, Mudgett-Hunter M, Haber E. Monoclonal antibodies as molecular probes to study structural heterogeneity between human and animal renins and other aspartyl proteinases. The Journal of Clinical Endocrinology and Metabolism. 62: 424-8. PMID 3510227 DOI: 10.1210/Jcem-62-2-424  1
1986 Babbitt BP, Matsueda G, Haber E, Unanue ER, Allen PM. Antigenic competition at the level of peptide-Ia binding. Proceedings of the National Academy of Sciences of the United States of America. 83: 4509-13. PMID 3459185 DOI: 10.1073/Pnas.83.12.4509  1
1986 Haber E. Renin inhibitors. Hypertension. 8: 1093-5. PMID 3025088  0.01
1986 Khaw BA, Gold HK, Yasuda T, Leinbach RC, Kanke M, Fallon JT, Barlai-Kovach M, Strauss HW, Sheehan F, Haber E. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation. 74: 501-8. PMID 3017604 DOI: 10.1161/01.Cir.74.3.501  1
1986 Haber E. Antibodies in cardiovascular diagnosis and therapy. Hospital Practice (Office Ed.). 21: 147-57, 161-2, 165-7. PMID 3005349  0.01
1986 Novotný J, Haber E. Static accessibility model of protein antigenicity: the case of scorpion neurotoxin. Biochemistry. 25: 6748-54. PMID 2432922 DOI: 10.1021/Bi00370A004  1
1986 Novotný J, Handschumacher M, Haber E. Location of antigenic epitopes on antibody molecules. Journal of Molecular Biology. 189: 715-21. PMID 2431154 DOI: 10.1016/0022-2836(86)90502-4  1
1986 Hui KY, Haber E, Matsueda GR. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production. Hybridoma. 5: 215-22. PMID 2429911  1
1986 Day RP, Hui KY, Gure M, Carlson WD, Dzau VJ, Haber E. A monoclonal antibody specific for the amino terminal sequence of human prorenin identifies a common epitope on renal and amniotic fluid inactive renins. Journal of Hypertension. 4: 375-81. PMID 2426349 DOI: 10.1097/00004872-198606000-00020  1
1986 Evin G, Carlson WD, Handschumacher M, Novotný J, Matsueda GR, Haber E, Bouhnik J, Galen FX, Ménard J, Corvol P. Study of the antigenic determinants of human renin. Hypertension. 8: II72-7. PMID 2424834 DOI: 10.1161/01.Hyp.8.6_Pt_2.Ii72  1
1986 Novotný J, Handschumacher M, Haber E, Bruccoleri RE, Carlson WB, Fanning DW, Smith JA, Rose GD. Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proceedings of the National Academy of Sciences of the United States of America. 83: 226-30. PMID 2417241 DOI: 10.1073/Pnas.83.2.226  1
1985 Hui KY, Haber E, Matsueda GR. Immunodetection of human fibrin using monoclonal antibody-64C5 in an extracorporeal chicken model. Thrombosis and Haemostasis. 54: 524-7. PMID 4082089 DOI: 10.1055/S-0038-1657889  1
1985 Haber E. Irvine H. Page lecture 1984. Basic science and clinical medicine. Problems and opportunities at the interface. Cleveland Clinic Quarterly. 52: 361-7. PMID 4064317  0.01
1985 Presti S, Friedman D, Saslow J, Doyle EF, Butler VP, Smith TW, Haber E. Digoxin toxicity in a premature infant: treatment with Fab fragments of digoxin-specific antibodies. Pediatric Cardiology. 6: 91-3. PMID 4059073 DOI: 10.1007/Bf02282744  1
1985 Mudgett-Hunter M, Anderson W, Haber E, Margolies MN. Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies. Molecular Immunology. 22: 477-88. PMID 4033667 DOI: 10.1016/0161-5890(85)90132-4  1
1985 Bode C, Matsueda GR, Hui KY, Haber E. Antibody-directed urokinase: a specific fibrinolytic agent. Science (New York, N.Y.). 229: 765-7. PMID 4023710 DOI: 10.1126/Science.4023710  1
1985 Haber E. Hypertension--where do we go from here? Hypertension. 7: 311-2. PMID 3997216  0.01
1985 Leikin J, Vogel S, Graff J, Goldman-Leikin R, Butler VP, Haber E, Smith TW. Use of fab fragments of digoxin-specific antibodies in the therapy of massive digoxin poisoning. Annals of Emergency Medicine. 14: 175-8. PMID 3970406 DOI: 10.1016/S0196-0644(85)81085-4  1
1985 Novotný J, Haber E. Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers. Proceedings of the National Academy of Sciences of the United States of America. 82: 4592-6. PMID 3927286  1
1985 Scott JA, Khaw BA, Locke E, Haber E, Homcy C. The role of free radical-mediated processes in oxygen-related damage in cultured murine myocardial cells. Circulation Research. 56: 72-7. PMID 3917873 DOI: 10.1161/01.Res.56.1.72  1
1985 Haber E, Dzau VJ. Molecular mechanisms that control renin secretion. Hypertension. 7: 853-4. PMID 3908311 DOI: 10.1161/01.Hyp.7.6.853  1
1985 Haber E. Defining the physiologic and pathophysiologic roles of renin: the role of specific inhibitors. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 5: A14-22. PMID 3887901 DOI: 10.1016/S0272-6386(85)80060-3  0.01
1985 Wenger TL, Butler VP, Haber E, Smith TW. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. Journal of the American College of Cardiology. 5: 118A-123A. PMID 3886748 DOI: 10.1016/S0735-1097(85)80471-X  1
1985 Haber E. Antibodies and digitalis: the modern revolution in the use of an ancient drug. Journal of the American College of Cardiology. 5: 111A-117A. PMID 3886747 DOI: 10.1016/S0735-1097(85)80470-8  0.01
1985 Carlson W, Karplus M, Haber E. Construction of a model for the three-dimensional structure of human renal renin. Hypertension. 7: 13-26. PMID 3884498 DOI: 10.1161/01.Hyp.7.1.13  1
1985 Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317: 359-61. PMID 3876513 DOI: 10.1038/317359A0  1
1985 Seidman CE, Bloch KD, Zisfein J, Smith JA, Haber E, Homcy C, Duby AD, Choi E, Graham RM, Seidman JG. Molecular studies of the atrial natriuretic factor gene. Hypertension. 7: I31-4. PMID 3158606 DOI: 10.1161/01.Hyp.7.3_Pt_2.I31  1
1985 Haber E. Will renin inhibitors influence decision-making in antihypertensive therapy? Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 3: S71-80. PMID 3003303  0.01
1985 Haber E. Quantifying cell death in the myocardium: myosin specific antibody in the evaluation of membrane defects. Journal of Molecular and Cellular Cardiology. 17: 53-8. PMID 2993633 DOI: 10.1016/0022-2828(85)90008-2  0.01
1985 Allen PM, Matsueda GR, Haber E, Unanue ER. Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. Journal of Immunology (Baltimore, Md. : 1950). 135: 368-73. PMID 2582039  1
1985 Nussberger J, Matsueda G, Re RN, Haber E. Recognition of peptide orientation: studies with angiotensin II in the guinea-pig. Molecular Immunology. 22: 619-21. PMID 2410776 DOI: 10.1016/0161-5890(85)90090-2  1
1984 Lechat P, Mudgett-Hunter M, Margolies MN, Haber E, Smith TW. Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments. The Journal of Pharmacology and Experimental Therapeutics. 229: 210-3. PMID 6707937  1
1984 Nussberger J, Mudgett-Hunter M, Matsueda G, Haber E. A monoclonal antibody specific for the carboxy-terminus of angiotensin II. Hybridoma. 3: 373-6. PMID 6526402 DOI: 10.1089/Hyb.1984.3.373  1
1984 Nussberger J, Re R, Matsueda GR, Haber E. A simplified radioimmunoassay for physiologically active angiotensin peptides [(1-8) octa- and (2-8) heptapeptides]. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 16: 606-10. PMID 6510892 DOI: 10.1055/s-2007-1014862  1
1984 Katus HA, Yasuda T, Gold HK, Leinbach RC, Strauss HW, Waksmonski C, Haber E, Khaw BA. Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. The American Journal of Cardiology. 54: 964-70. PMID 6496359 DOI: 10.1016/S0002-9149(84)80126-5  1
1984 Khaw BA, Mattis JA, Melincoff G, Strauss HW, Gold HK, Haber E. Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. Hybridoma. 3: 11-23. PMID 6469268 DOI: 10.1089/Hyb.1984.3.11  1
1984 Carlson W, Handschumacher M, Karplus M, Haber E. Studies of the three-dimensional structure of human renin and its inhibitors. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 2: S281-4. PMID 6400375  1
1984 Kashuk KB, Haber E. Tendon and ligament prostheses. Clinics in Podiatry. 1: 131-43. PMID 6399225  0.01
1984 Dzau VJ, Devine D, Mudgett-Hunter M, Haber E. Monoclonal antibodies specific for human renin. Transactions of the Association of American Physicians. 97: 146-50. PMID 6398945  1
1984 Dzau VJ, Kopelman RI, Barger AC, Haber E. Comparison of renin-specific IgG and antibody fragments in studies of blood pressure regulation. The American Journal of Physiology. 246: H404-9. PMID 6367489 DOI: 10.1152/Ajpheart.1984.246.3.H404  1
1984 Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homcy C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science (New York, N.Y.). 225: 324-6. PMID 6234658 DOI: 10.1126/Science.6234658  1
1984 Haber E. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does? Journal of Hypertension. 2: 223-30. PMID 6099385 DOI: 10.1097/00004872-198406000-00002  0.01
1984 Haber E. Renin inhibitors. The New England Journal of Medicine. 311: 1631-3. PMID 6095079 DOI: 10.1056/NEJM198412203112511  0.01
1983 Khaw BA, Strauss HW, Pohost GM, Fallon JT, Katus HA, Haber E. Relation of immediate and delayed thallium-201 distribution to localization of iodine-125 antimyosin antibody in acute experimental myocardial infarction. The American Journal of Cardiology. 51: 1428-32. PMID 6846171 DOI: 10.1016/0002-9149(83)90324-7  1
1983 Rose DR, Seaton BA, Petsko GA, Novotný J, Margolies MN, Locke E, Haber E. Crystallization of the Fab fragment of a monoclonal anti-digoxin antibody and its complex with digoxin. Journal of Molecular Biology. 165: 203-6. PMID 6842605 DOI: 10.1016/S0022-2836(83)80252-6  1
1983 Ware JA, Young JB, Luchi RJ, Smith TW, Haber E, Butler VP. Treatment of severe digoxin toxicity with digoxin-specific antibodies: a case report. Texas Medicine. 79: 57-9. PMID 6829019  1
1983 Nussberger J, Matsueda GR, Re R, Haber E. Selectivity of angiotensin II antisera. Journal of Immunological Methods. 56: 85-96. PMID 6827092 DOI: 10.1016/0022-1759(83)90051-0  1
1983 Hui KY, Haber E, Matsueda GR. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science (New York, N.Y.). 222: 1129-32. PMID 6648524 DOI: 10.1126/Science.6648524  1
1983 Novotný J, Bruccoleri R, Newell J, Murphy D, Haber E, Karplus M. Molecular anatomy of the antibody binding site. The Journal of Biological Chemistry. 258: 14433-7. PMID 6643494  1
1983 Young JD, Costello CE, Van Langenhove A, Haber E, Matsueda GR. Synthesis of a cyclic fibrin-like peptide and its analysis by fast atom bombardment mass spectrometry. International Journal of Peptide and Protein Research. 22: 374-80. PMID 6629650 DOI: 10.1111/J.1399-3011.1983.Tb02105.X  1
1983 Haber E, Zusman R, Burton J, Dzau VJ, Barger AC. Is renin a factor in the etiology of essential hypertension? Hypertension. 5: V8-15. PMID 6418650 DOI: 10.1161/01.Hyp.5.6_Pt_3.V8  1
1983 Zusman RM, Burton J, Christensen D, Nussberger J, Dodds A, Haber E. Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action. Transactions of the Association of American Physicians. 96: 365-74. PMID 6388104  1
1983 Dzau VJ, Devine D, Mudgett-Hunter M, Kopelman RI, Barger AC, Haber E. Antibodies as specific renin inhibitors: studies with polyclonal and monoclonal antibodies and Fab fragments. Clinical and Experimental Hypertension. Part a, Theory and Practice. 5: 1207-20. PMID 6357564 DOI: 10.3109/10641968309048852  1
1983 Haber E. Inhibitors of renin: present and future. Clinical and Experimental Hypertension. Part a, Theory and Practice. 5: 1193-205. PMID 6357563 DOI: 10.3109/10641968309048851  0.01
1983 Pacella BL, Hui KY, Haber E, Matsueda GR. Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites. Molecular Immunology. 20: 521-7. PMID 6348513 DOI: 10.1016/0161-5890(83)90090-1  1
1983 Haber E. Antibodies as models for rational drug design. Biochemical Pharmacology. 32: 1967-77. PMID 6347201 DOI: 10.1016/0006-2952(83)90414-8  0.01
1983 Ikemoto F, Dzau VJ, Haber E, Takaori K, Yamamoto K. Immunoaffinity chromatography of canine high-molecular-weight renin: partial purification and characterization. Clinical Science (London, England : 1979). 65: 117-20. PMID 6345047 DOI: 10.1042/Cs0650117  1
1983 Haber E. Immunologic approaches to the inhibition of renin and the adrenergic system. Federation Proceedings. 42: 2661-6. PMID 6305728  0.01
1983 Frame LH, Lopez JA, Khaw BA, Fallon JT, Haber E, Powell WJ. Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2. The Journal of Clinical Investigation. 72: 535-44. PMID 6223942 DOI: 10.1172/Jci111001  1
1983 Haber E. Peptide inhibitors of renin in cardiovascular studies. Federation Proceedings. 42: 3155-61. PMID 6196232  0.01
1983 Mudgett-Hunter M, Budzik GP, Donahoe PK, Khaw BA, Margolies MN, Ridgeway EC, Haber E. Monoclonal antibodies as physiologic probes. Basic Life Sciences. 25: 101-28. PMID 6190474 DOI: 10.1007/978-1-4684-4460-5_8  1
1983 Marciniak RA, Wands JR, Bruns RR, Malchesky PS, Nose Y, Haber E. Quantitative removal of hepatitis B viral antigens from serum by a monoclonal IgM coupled to a biocompatible solid-phase support. Proceedings of the National Academy of Sciences of the United States of America. 80: 3821-5. PMID 6190181 DOI: 10.1073/Pnas.80.12.3821  0.01
1982 Potter M, Newell JB, Rudikoff S, Haber E. Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Molecular Immunology. 19: 1619-30. PMID 7162519 DOI: 10.1016/0161-5890(82)90273-5  1
1982 Khaw BA, Strauss HW, Carvalho A, Locke E, Gold HK, Haber E. Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 23: 1011-9. PMID 7131084  1
1982 Ridge RJ, Matsueda GR, Haber E, Matsueda R. Sulfur protection with the 3-nitro-2-pyridine sulfenyl group in solid-phase peptide synthesis. International Journal of Peptide and Protein Research. 19: 490-8. PMID 7118419 DOI: 10.1111/J.1399-3011.1982.Tb02634.X  1
1982 Murphy DJ, Bremner WF, Haber E, Butler VP, Smith TW, Gaum WE. Massive digoxin poisoning treated with Fab fragments of digoxin-specific antibodies. Pediatrics. 70: 472-3. PMID 7110823  1
1982 Zucker AR, Lacina SJ, DasGupta DS, Fozzard HA, Mehlman D, Butler VP, Haber E, Smith TW. Fab fragments of digoxin-specific antibodies used to reverse ventricular fibrillation induced by digoxin ingestion in a child. Pediatrics. 70: 468-71. PMID 7110822  1
1982 Khaw BA, Scott J, Fallon JT, Cahill SL, Haber E, Homcy C. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science (New York, N.Y.). 217: 1050-3. PMID 7051286  1
1982 Dzau VJ, Brenner A, Wolfsohn S, Haber E. Characterization of antibodies to canine renal renin. Studies of interspecies homology of renin using antibodies as probe. Hypertension. 4: 341-7. PMID 7040231 DOI: 10.1161/01.Hyp.4.3.341  1
1982 Lee DC, Johnson RA, Bingham JB, Leahy M, Dinsmore RE, Goroll AH, Newell JB, Strauss HW, Haber E. Heart failure in outpatients: a randomized trial of digoxin versus placebo. The New England Journal of Medicine. 306: 699-705. PMID 7038483 DOI: 10.1056/Nejm198203253061202  1
1982 Re R, Fallon JT, Dzau V, Ouay SC, Haber E. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sciences. 30: 99-106. PMID 7033709 DOI: 10.1016/0024-3205(82)90641-5  1
1982 Haber E, Carlson W. Are inactive renins in plasma and kidney related to prorenin? Clinical and Experimental Hypertension. Part a, Theory and Practice. 4: 1995-2006. PMID 6756675 DOI: 10.3109/10641968209062365  1
1982 Smith TW, Butler VP, Haber E, Fozzard H, Marcus FI, Bremner WF, Schulman IC, Phillips A. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. The New England Journal of Medicine. 307: 1357-62. PMID 6752715 DOI: 10.1056/Nejm198211253072201  1
1982 Homcy CJ, Rockson SG, Haber E. An antiidiotypic antibody that recognizes the beta-adrenergic receptor. The Journal of Clinical Investigation. 69: 1147-54. PMID 6279698 DOI: 10.1172/Jci110550  1
1982 Graham RM, Hess HJ, Haber E, Homcy CJ. Antibodies to the alpha 1- and alpha 2-selective antagonists prazosin and yohimbine as probes of the alpha-adrenergic binding sites. Hypertension. 4: 183-7. PMID 6279501 DOI: 10.1161/01.Hyp.4.3_Pt_2.183  1
1982 Haber E, Katus HA, Hurrell JG, Matsueda GR, Ehrlich P, Zurawski VR, Khaw BA. Detection and quantification of myocardial cell death: application of monoclonal antibodies specific for cardiac myosin. Journal of Molecular and Cellular Cardiology. 14: 139-46. PMID 6183437 DOI: 10.1016/0022-2828(82)90142-0  1
1982 Re R, Fintel D, Bryan S, Haber E, Labiche R, Parab M. Studies on two novel angiotensin II actions. Clinical and Experimental Hypertension. Part a, Theory and Practice. 4: 1649-60. PMID 6183031 DOI: 10.3109/10641968209061631  1
1982 Hunter MM, Margolies MN, Ju A, Haber E. High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. Journal of Immunology (Baltimore, Md. : 1950). 129: 1165-72. PMID 6179995  1
1982 Katus HA, Hurrell JG, Matsueda GR, Ehrlich P, Zurawski VR, Khaw BA, Haber E. Increased specificity in human cardiac-myosin radioimmunoassay utilizing two monoclonal antibodies in a double sandwich assay. Molecular Immunology. 19: 451-5. PMID 6178967 DOI: 10.1016/0161-5890(82)90211-5  1
1982 Haber E, Pfitzer EA. Immunological aspects of toxicology--a workshop. Regulatory Toxicology and Pharmacology : Rtp. 2: 247-65. PMID 6137033 DOI: 10.1016/0273-2300(82)90020-4  0.01
1982 Haber E. Antibodies in vivo. Pharmacological Reviews. 34: 77-84. PMID 6122224  0.01
1982 Haber E. Immunological probes in cardiovascular disease. British Heart Journal. 47: 1-10. PMID 6119995  0.01
1982 Haber E. Antibodies in Vivo Pharmacological Reviews. 34: 77-84. DOI: 10.1007/978-1-4684-4964-8_28  0.01
1981 Dzau V, Mudgett-Hunter M, Kapler G, Haber E. Monoclonal antibodies binding renal renin. Hypertension. 3: II-4-8. PMID 6795117 DOI: 10.1161/01.Hyp.3.6_Pt_2.Ii-4  1
1981 Matsueda GR, Haber E, Margolies MN. Quantitative solid-phase Edman degradation for evaluation of extended solid-phase peptide synthesis. Biochemistry. 20: 2571-80. PMID 6786336 DOI: 10.1021/Bi00512A032  1
1981 Rockson SG, Homcy CJ, Quinn P, Manders WT, Haber E, Vatner SF. Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs. The Journal of Clinical Investigation. 67: 319-27. PMID 6257759 DOI: 10.1172/Jci110038  1
1981 Hurrell JG, Katus HA, Khaw BA, Haber E, Zurawski VR. Monoclonal antibodies directed against human myoglobin: characterization and application in a bideterminant radioimmunoassay. Journal of Immunological Methods. 45: 249-54. PMID 6169768 DOI: 10.1016/0022-1759(81)90303-3  1
1980 Hurrell JG, Black PH, Haber E, Zurawski VR. A rapid and efficient procedure for the removal of nonviable cells from suspension culture of lymphoid cell lines. The Australian Journal of Experimental Biology and Medical Science. 58: 373-6. PMID 7436883 DOI: 10.1038/Icb.1980.36  1
1980 Matsueda GR, Haber E. The use of an internal reference amino acid for the evaluation of reactions in solid-phase peptide synthesis. Analytical Biochemistry. 104: 215-27. PMID 7386879 DOI: 10.1016/0003-2697(80)90301-2  1
1980 Khaw BA, Fallon FT, Strauss HW, Haber E. Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. Science (New York, N.Y.). 209: 295-7. PMID 7384803  1
1980 Epstein M, Lifschitz MD, Re R, Haber E. Dissociation of renin--aldosterone and renal prostaglandin E during volume expansion induced by immersion in normal man. Clinical Science (London, England : 1979). 59: 55-62. PMID 7009025  1
1980 Cody RJ, Burton J, Evin G, Poulsen K, Herd JA, Haber E. A substrate analog inhibitor of renin that is effective in vivo. Biochemical and Biophysical Research Communications. 97: 230-5. PMID 7006602 DOI: 10.1016/S0006-291X(80)80158-6  1
1980 Dzau VJ, Brenner A, Emmett N, Haber E. Identification of renin and renin-like enzymes in rat brain by a renin-specific antibody. Clinical Science (London, England : 1979). 59: 45s-47s. PMID 7004734 DOI: 10.1042/Cs059045S  1
1980 Dzau VJ, Kopelman RI, Barger AC, Haber E. Renin-specific antibody for study of cardiovascular homeostasis. Science (New York, N.Y.). 207: 1091-3. PMID 6986653 DOI: 10.1126/Science.6986653  1
1980 Aeberhard P, Butler VP, Smith TW, Haber E, Eng DT, Brau J, Chalom A, Glatt B, Thébaut JF, Delangenhagen B, Morin B. [Treatment of massive digitalis poisoning (20 mg of digitoxin) with anti-digoxin antibody fragments (Fab)]. Archives Des Maladies Du Coeur Et Des Vaisseaux. 73: 1471-8. PMID 6779736  1
1980 Haber E. The Fifth Volhard Lecture. Specific inhibitors of renin. Clinical Science (London, England : 1979). 59: 7s-19s. PMID 6778646 DOI: 10.1042/Cs059007S  0.01
1980 Rockson SG, Homcy CJ, Haber E. Anti-alprenolol antibodies in the rabbit. A new probe for the study of beta-adrenergic receptor interaction. Circulation Research. 46: 808-13. PMID 6247081 DOI: 10.1161/01.Res.46.6.808  1
1980 Brown CA, Zusman RM, Haber E. Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis. Circulation Research. 46: 802-7. PMID 6247080 DOI: 10.1161/01.Res.46.6.802  1
1980 Burton J, Cody RJ, Herd JA, Haber E. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension. Proceedings of the National Academy of Sciences of the United States of America. 77: 5476-9. PMID 6159648 DOI: 10.1073/Pnas.77.9.5476  1
1980 Ehrlich PH, Matsueda GR, Margolies MN, Husain SS, Haber E. Isolation of an active heavy-chain variable domain from a homogeneous rabbit antibody by cathepsin B digestion of the aminoethylated heavy chain. Biochemistry. 19: 4091-6. PMID 6157405 DOI: 10.1021/Bi00558A029  1
1979 Haber E, Burton J. Inhibitors of renin and their utility in physiologic studies. Federation Proceedings. 38: 2768-73. PMID 510563  1
1979 Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation. 60: 1527-31. PMID 498480 DOI: 10.1161/01.Cir.60.7.1527  1
1979 Dzau VJ, Slater EE, Haber E. Complete purification of dog renal renin. Biochemistry. 18: 5224-8. PMID 497179 DOI: 10.1021/Bi00590A029  1
1979 Torchilin VP, Khaw BA, Smirnov VN, Haber E. Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochemical and Biophysical Research Communications. 89: 1114-9. PMID 496941 DOI: 10.1016/0006-291X(79)92123-5  1
1979 Epstein M, Re R, Preston S, Haber E. Comparison of the suppressive effects of water immersion and saline administration on renin-aldosterone in normal man. The Journal of Clinical Endocrinology and Metabolism. 49: 358-63. PMID 468969 DOI: 10.1210/jcem-49-3-358  1
1979 Slater EE, Haber E. Inactive renin--"through a glass darkly". The New England Journal of Medicine. 301: 429-30. PMID 460346 DOI: 10.1056/Nejm197908233010810  1
1979 Haber E. The role of renin in the control of the circulation and in hypertensive disease. La Ricerca in Clinica E in Laboratorio. 9: 389-409. PMID 397605 DOI: 10.1007/Bf02904575  0.01
1979 Slater EE, Gounaris AD, Haber E. Isolation of a renal thiol protease that activates inactive plasma renin. Clinical Science (London, England : 1979). 57: 93s-96s. PMID 396096 DOI: 10.1042/Cs057093S  1
1979 Brown CA, Zusman RM, Haber E. Characterization of an angiotensin binding site in rabbit renomedullary interstitial cells in tissue culture: correlation with prostaglandin biosynthesis. Transactions of the Association of American Physicians. 92: 169-74. PMID 232942  1
1979 Haber E. The renin-angiotensin system and hypertension. Kidney International. 15: 427-44. PMID 229303 DOI: 10.1038/Ki.1979.55  0.01
1979 Wrenn S, Haber E. An antibody specific for the propranolol binding site of cardiac muscle. The Journal of Biological Chemistry. 254: 6577-82. PMID 221503  1
1979 Wrenn S, Homcy C, Haber E. Evidence for the beta-adrenergic receptor regulation of membrane-bound catechol-O-methyltransferase activity in myocardium. The Journal of Biological Chemistry. 254: 5708-12. PMID 221478  1
1979 Haber E. Renin and vascular homeostasis during anesthesia. Anesthesiology. 50: 83-4. PMID 219729  0.01
1979 Smith TW, Lloyd BL, Spicer N, Haber E. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon. Clinical and Experimental Immunology. 36: 384-96. PMID 114346  1
1979 Ehrlich PH, Matsueda GR, Haber E, Margolies MN. Isolation and characterization of an active variable domain from a homogeneous rabbit antibody light chain. Biochemistry. 18: 4411-8. PMID 114216 DOI: 10.1021/Bi00587A022  1
1978 Epstein M, Sancho J, Perez G, Haber E, Re R, Loutzenhiser R. Volume as a determinant of plasma aldosterone in anephric man. The Journal of Clinical Endocrinology and Metabolism. 46: 309-16. PMID 750607 DOI: 10.1210/jcem-46-2-309  1
1978 Re RN, Sancho J, Kliman B, Haber E. The characterization of low renin hypertension by plasma renin activity and plasma aldosterone concentration. The Journal of Clinical Endocrinology and Metabolism. 46: 189-95. PMID 750601 DOI: 10.1210/Jcem-46-2-189  1
1978 Khaw BA, Gold HK, Leinbach RC, Fallon JT, Strauss W, Pohost GM, Haber E. Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments. Circulation. 58: 1137-42. PMID 709769 DOI: 10.1161/01.Cir.58.6.1137  1
1978 Khaw BA, Gold HK, Fallon JT, Haber E. Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains. Circulation. 58: 1130-6. PMID 709768 DOI: 10.1161/01.Cir.58.6.1130  1
1978 Khaw BA, Beller GA, Haber E. Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin. Circulation. 57: 743-50. PMID 630683 DOI: 10.1161/01.Cir.57.4.743  1
1978 Slater EE, Haber E. A large form of renin from normal human kidney. The Journal of Clinical Endocrinology and Metabolism. 47: 105-9. PMID 400710 DOI: 10.1210/Jcem-47-1-105  1
1978 Hardin JA, Cronlund M, Haber E, Bloch KJ. Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity. The American Journal of Medicine. 65: 430-6. PMID 309726 DOI: 10.1016/0002-9343(78)90769-6  1
1978 Slater EE, Cohn RC, Dzau VJ, Haber E. Purification of human renal renin. Clinical Science and Molecular Medicine. Supplement. 4: 117s-119s. PMID 282038 DOI: 10.1042/Cs055117S  1
1978 Homcy C, Wrenn S, Haber E. Affinity purification of cardiac adenylate cyclase: dependence on prior hydrophobic resolution. Proceedings of the National Academy of Sciences of the United States of America. 75: 59-63. PMID 272673 DOI: 10.1073/Pnas.75.1.59  1
1978 Sancho J, Haber E. A direct microassay for aldosterone in plasma extracts. The Journal of Clinical Endocrinology and Metabolism. 47: 391-6. PMID 263305 DOI: 10.1210/Jcem-47-2-391  1
1978 Zurawski VR, Spedden SE, Black PH, Haber E. Clones of human lymphoblastoid cell lines producing antibody to tetanus toxoid. Current Topics in Microbiology and Immunology. 81: 152-5. PMID 211002  1
1978 Haber E. Renin inhibitors. The New England Journal of Medicine. 298: 1023-5. PMID 205787 DOI: 10.1056/NEJM197805042981812  0.01
1978 Zurawski VR, Haber E, Black PH. Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines. Science (New York, N.Y.). 199: 1439-41. PMID 204013 DOI: 10.1126/Science.204013  1
1978 Re R, Novelline R, Escourrou MT, Athanasoulis C, Burton J, Haber E. Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis. The New England Journal of Medicine. 298: 582-6. PMID 203850 DOI: 10.1056/Nejm197803162981102  1
1978 Rosemblatt MS, Haber E. Isolation of an active variable-domain fragment from a homogeneous rabbit antibody heavy chain. Physiochemical and immunological properties. Biochemistry. 17: 3877-82. PMID 100137 DOI: 10.1021/Bi00611A031  0.01
1978 Cannon LE, Margolies MN, Haber E. Light chain variable region sequence of rabbit antipneumococcal type III polysaccharide antibody 3368. Biochemistry. 17: 3101-9. PMID 100133 DOI: 10.1021/Bi00608A025  1
1978 Ehrlich PH, Matsueda GR, Margolies MN, Haber E. Preparation of an active Fd fragment by cyanogen bromide cleavage of an IgG heavy chain from a homogeneous rabbit antibody. Immunochemistry. 15: 937-40. PMID 35462 DOI: 10.1016/0161-5890(78)90127-X  1
1978 Zurawski VR, Novotný J, Haber E, Margolies MN. Antibodies of restricted heterogeneity directed against the cardiac glycoside digoxin. Journal of Immunology (Baltimore, Md. : 1950). 121: 122-9. PMID 27558  1
1977 Homcy CJ, Wrenn SM, Haber E. Demonstration of the hydrophilic character of adenylate cyclase following hydrophobic resolution on immobilized alkyl residues. Critical role of alkyl chain length. The Journal of Biological Chemistry. 252: 8957-64. PMID 925032  1
1977 Epstein M, Levinson R, Sancho J, Haber E, Re R. Characterization of the renin-aldosterone system in decompensated cirrhosis. Circulation Research. 41: 818-29. PMID 923033 DOI: 10.1161/01.Res.41.6.818  1
1977 Beller GA, Khaw BA, Haber E, Smith TW. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate. Circulation. 55: 74-8. PMID 830221 DOI: 10.1161/01.Cir.55.1.74  1
1977 Novotný J, FranÄ•k F, Margolies MN, Haber E. Amino acid sequence of normal (microheterogeneous) porcine immunoglobulin lambda chains. Biochemistry. 16: 3765-72. PMID 409425  1
1977 Butler VP, Schmidt DH, Smith TW, Haber E, Raynor BD, Demartini P. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. The Journal of Clinical Investigation. 59: 345-59. PMID 299860 DOI: 10.1172/Jci108647  1
1977 Butler VP, Smith TW, Schmidt DH, Haber E. Immunological reversal of the effects of digoxin. Federation Proceedings. 36: 2235-41. PMID 142027  1
1977 Haber E, Margolies MN, Cannon LE. Origins of antibody diversity: insight gained from amino acid sequence studies of elicited antibodies. Cold Spring Harbor Symposia On Quantitative Biology. 41: 647-59. PMID 19193  1
1977 Haber E, Slater EE. Purification of renin: a review. Circulation Research. 40: I36-40. PMID 15735  1
1976 Khaw BA, Beller GA, Haber E, Smith TW. Localization of cardiac myosin-specific antibody in myocardial infarction. Journal of Clinical Investigation. 58: 439-446. PMID 956377 DOI: 10.1172/Jci108488  1
1976 Smith TW, Haber E, Yeatman L, Butler VP. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. The New England Journal of Medicine. 294: 797-800. PMID 943040 DOI: 10.1056/Nejm197604082941501  1
1976 Cronlund M, Hardin J, Burton J, Lee L, Haber E, Bloch KJ. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus. Journal of Clinical Investigation. 58: 142-151. PMID 932202 DOI: 10.1172/Jci108443  1
1976 Watkins L, Burton JA, Haber E, Cant JR, Smith FW, Barger AC. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. The Journal of Clinical Investigation. 57: 1606-17. PMID 180056 DOI: 10.1172/Jci108431  1
1976 Sancho J, Re R, Burton J, Barger AC, Haber E. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation. 53: 400-5. PMID 174834 DOI: 10.1161/01.Cir.53.3.400  1
1976 Haber E, Wrenn S. Problems in identification of the beta adrenergic receptor Physiological Reviews. 56: 317-338. PMID 6980 DOI: 10.1152/PHYSREV.1976.56.2.317  1
1975 Epstein M, Pins DS, Sancho J, Haber E. Suppression of plasma renin and plasma aldosterone during water immersion in normal man. The Journal of Clinical Endocrinology and Metabolism. 41: 618-25. PMID 1159066 DOI: 10.1210/jcem-41-3-618  1
1975 Margolies MN, Cannon LE, Strosberg AD, Haber E. Diversity of light chain variable region sequences among rabbit antibodies elicited by the same antigens. Proceedings of the National Academy of Sciences of the United States of America. 72: 2180-4. PMID 1094456 DOI: 10.1073/Pnas.72.6.2180  1
1975 Haber E, Sancho J, Re R, Burton J, Barger AC. The role of the renin--angiotensin--aldosterone system in cardiovascular homeostasis in normal man. Clinical Science and Molecular Medicine. Supplement. 2: 49s-52s. PMID 1077790 DOI: 10.1042/Cs048049S  1
1975 Miller ED, Samuels AI, Haber E, Barger AC. Inhibition of angiotensin conversion and prevention of renal hypertension. The American Journal of Physiology. 228: 448-53. PMID 235218 DOI: 10.1152/Ajplegacy.1975.228.2.448  1
1974 Tagawa H, Gutmann FD, Haber E, Miller ED, Samuels AI, Barger AC. Reversible renovascular hypertension and renal arterial pressure. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 146: 975-82. PMID 4424032 DOI: 10.3181/00379727-146-38231  1
1974 Oparil S, Koerner TJ, Haber E. Effects of pH and Enzyme Inhibitors on Apparent Generation of Angiotensin I in Human Plasma. The Journal of Clinical Endocrinology and Metabolism. 39: 965-968. PMID 4370811 DOI: 10.1210/Jcem-39-5-965  1
1974 Oparil S, Haber E. The renin-angiotensin system (first of two parts). The New England Journal of Medicine. 291: 389-401. PMID 4367917 DOI: 10.1056/Nejm197408222910805  1
1974 Vetter W, Freedlender E, Haber E. Specificity of antialdosterone antibodies in relation to the site of coupling Clinical Immunology and Immunopathology. 2: 361-372. PMID 4133190 DOI: 10.1016/0090-1229(74)90054-3  1
1973 Christensen JM, Hippe E, Olesen H, Rye M, Haber E, Lee L, Thomsen J. Purification of human intrinsic factor by affinity chromatography. Biochimica Et Biophysica Acta. 303: 319-32. PMID 4736293 DOI: 10.1016/0005-2795(73)90363-2  1
1973 Gutmann FD, Tagawa H, Haber E, Barger AC. Renal arterial pressure, renin secretion, and blood pressure control in trained dogs. The American Journal of Physiology. 224: 66-72. PMID 4683309 DOI: 10.1152/Ajplegacy.1973.224.1.66  1
1973 Poulsen K, Burton JA, Haber E. Synthesis of renin inhibitors. Clinical Science and Molecular Medicine. Supplement. 45: 239s-41. PMID 4361400 DOI: 10.1042/Cs045239S  1
1973 Poulsen K, Burton J, Haber E. Competitive inhibitors of renin. Biochemistry. 12: 3877-3882. PMID 4355542 DOI: 10.1021/Bi00744A013  1
1973 Lefkowitz RJ, Haber E. Physiological receptors as physicochemical entities. Circulation Research. 32: Suppl 1:46-52. PMID 4351359  1
1973 Lefkowitz RJ, Sharp GW, Haber E. Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. The Journal of Biological Chemistry. 248: 342-9. PMID 4144255  1
1972 Lefkowitz RJ, Haber E, O'Hara D. Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. Proceedings of the National Academy of Sciences of the United States of America. 69: 2828-32. PMID 4507606 DOI: 10.1073/Pnas.69.10.2828  1
1972 Miller ED, Samuels AI, Haber E, Barger AC. Inhibition of angiotensin conversion in experimental renovascular hypertension. Science (New York, N.Y.). 177: 1108-9. PMID 4341125 DOI: 10.1126/Science.177.4054.1108  1
1972 Strosberg AD, Fraser KJ, Margolies MN, Haber E. Amino acid sequence of rabbit pneumococcal antibody. I. Light-chain cysteine-containing peptides. Biochemistry. 11: 4978-85. PMID 4118103 DOI: 10.1021/Bi00776A017  1
1972 Vetter W, Freedlender E, Haber E. Production And Characterization Of Antibodies Elicited By Different Aldosterone-Protein Conjugates European Journal of Endocrinology. 68. DOI: 10.1530/Acta.0.069S032  1
1971 Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB. Digitalis intoxication. A prospective clinical study with serum level correlations. The New England Journal of Medicine. 284: 989-997. PMID 5553483 DOI: 10.1056/Nejm197105062841801  1
1971 Lefkowitz RJ, Haber E. A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America. 68: 1773-7. PMID 4399664 DOI: 10.1073/Pnas.68.8.1773  1
1971 Oparil S, Tregear GW, Koerner T, Barnes BA, Haber E. Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog Circulation Research. 29: 682-690. PMID 4331484 DOI: 10.1161/01.Res.29.6.682  1
1971 Oparil S, Haber E. Renin in differential diagnosis of hypertension American Heart Journal. 82: 568-570. PMID 4329421 DOI: 10.1016/0002-8703(71)90244-4  1
1971 Jaton JC, Waterfield MD, Margolies MN, Bloch KJ, Haber E. Variation in the primary structure of antibodies during the course of immunization. Biochemistry. 10: 1583-7. PMID 4103273 DOI: 10.1021/bi00785a012  1
1970 Smith TW, Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration Journal of Clinical Investigation. 49: 2377-2386. PMID 5480861 DOI: 10.1172/Jci106457  1
1970 Haber E, Caulfield JB. Case 14-1970 The New England Journal of Medicine. 282: 737-744. PMID 5416206 DOI: 10.1056/Nejm197003262821309  0.01
1970 Jaton JC, Waterfield MD, Margolies MN, Haber E. Isolation and characterization of structurally homogeneous antibodies from antipneumococcal sera. Proceedings of the National Academy of Sciences of the United States of America. 66: 959-66. PMID 4393268 DOI: 10.1073/Pnas.66.3.959  1
1970 Oparil S, Vassaux C, Sanders CA, Haber E. Role of renin in acute postural homeostasis. Circulation. 41: 89-95. PMID 4316040 DOI: 10.1161/01.Cir.41.1.89  1
1970 Oparil S, Sanders CA, Haber E. In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood. Circulation Research. 26: 591-9. PMID 4315298 DOI: 10.1161/01.Res.26.5.591  1
1970 Smith TW, Butler VP, Haber E. Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. Biochemistry. 9: 331-337. PMID 4312850 DOI: 10.1021/Bi00804A020  1
1969 Smith TW, Butler VP, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. The New England Journal of Medicine. 281: 1212-1216. PMID 5388455 DOI: 10.1056/Nejm196911272812203  1
1969 Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application Of A Radioimmunoassay For Angiotensin I To The Physiologic Measurements Of Plasma Renin Activity In Normal Human Subjects. The Journal of Clinical Endocrinology and Metabolism. 29: 1349-1355. PMID 4311082 DOI: 10.1210/Jcem-29-10-1349  1
1969 Haber E. Recent Developments in Pathophysiologic Studies of the Renin-Angiotensin System The New England Journal of Medicine. 280: 148-155. PMID 4302194 DOI: 10.1056/Nejm196901162800308  0.01
1969 Talamo RC, Haber E, Austen KF. A radioimmunoassay for bradykinin in plasma and synovial fluid Journal of Laboratory and Clinical Medicine. 74: 816-827. DOI: 10.5555/Uri:Pii:0022214369902431  0.01
1968 Cathou RE, Kulczycki A, Haber E. Structural features of γ-immunoglobulin, antibody, and their fragments. Circular dichroism studies Biochemistry. 7: 3958-3964. PMID 5722265 DOI: 10.1021/Bi00851A024  1
1967 Vallotton MB, Page LB, Haber E. Radioimmunoassay of angiotensin in human plasma. Nature. 215: 714-715. PMID 4293847 DOI: 10.1038/215714A0  1
1966 Haber E, Scully RE. Case 55-1966 The New England Journal of Medicine. 275: 1436-1445. PMID 4224854 DOI: 10.1056/Nejm196612222752510  1
1966 Haber E, Scully RE. Case 31-1966 The New England Journal of Medicine. 275: 101-108. PMID 4222982 DOI: 10.1056/Nejm196607142750212  1
1965 HABER E, PAGE LB, JACOBY GA. SYNTHESIS OF ANTIGENIC BRANCH-CHAIN COPOLYMERS OF ANGIOTENSIN AND Biochemistry. 4: 693-698. PMID 14323573 DOI: 10.1021/Bi00880A013  1
1964 HABER E. RECOVERY OF ANTIGENIC SPECIFICITY AFTER DENATURATION AND COMPLETE Proceedings of the National Academy of Sciences of the United States Of. 52: 1099-1106. PMID 14224389 DOI: 10.1073/Pnas.52.4.1099  1
1964 Spann JF, Moellering RC, Haber E, Wheeler EO. Arrhythmias In Acute Myocardial Infarction; A Study Utilizing An Electrocardiographic Monitor For Automatic Detection And Recording Of Arrhythmias. The New England Journal of Medicine. 271: 427-431. PMID 14171811 DOI: 10.1056/Nejm196408272710901  0.01
1964 Haber E, Bennett JC, Mills JA. The relationship of the three dimensional conformation of proteins to their antigenic specificity Medicine (United States). 43: 305-314. PMID 14168743  1
1963 MILLS JA, HABER E. THE EFFECT ON ANTIGENIC SPECIFICITY OF CHANGES IN THE MOLECULAR Journal of Immunology (Baltimore, Md. : 1950). 91: 536-540. PMID 14082041  1
1963 BENNETT JC, HABER E. Studies on antigen conformation during antibody purification The Journal of Biological Chemistry. 238: 1362-1366. PMID 13967474  1
1962 HABER E, BENNETT JC. Polarization of fluorescence as a measure of antigen-antibody interaction Proceedings of the National Academy of Sciences of the United States of America. 48: 1935-1942. PMID 13951630 DOI: 10.1073/Pnas.48.11.1935  1
1962 HABER E, ANFINSEN CB. Side-chain interactions governing the pairing of half-cystine residues in ribonuclease. The Journal of Biological Chemistry. 237: 1839-44. PMID 13903380  1
1961 HABER E, ANFINSEN CB. Regeneration of enzyme activity by air oxidation of reduced subtilisin-modified ribonuclease. The Journal of Biological Chemistry. 236: 422-4. PMID 13710229  1
1961 ANFINSEN CB, HABER E. Studies on the reduction and re-formation of protein disulfide bonds. The Journal of Biological Chemistry. 236: 1361-3. PMID 13683523  1
1961 ANFINSEN CB, HABER E, SELA M, WHITE FH. The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proceedings of the National Academy of Sciences of the United States of America. 47: 1309-14. PMID 13683522 DOI: 10.1073/Pnas.47.9.1309  1
1959 Haber E, Osborne RKL. Icterus and febrile reactions in response to isonicotinic acid hydrazine; report of two cases and review of the literature. The New England Journal of Medicine. 260: 417-420. PMID 13632903 DOI: 10.1056/Nejm195902262600904  0.01
Show low-probability matches.